{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 895325, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:05:01Z", "timestamp": 1574172301953}, "reference-count": 18, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1038/sj.leu.2403061", "type": "journal-article", "created": {"date-parts": [[2003, 9, 11]], "date-time": "2003-09-11T14:47:26Z", "timestamp": 1063291646000}, "page": "1851-1857", "source": "Crossref", "is-referenced-by-count": 49, "title": ["t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"], "prefix": "10.1038", "volume": "17", "author": [{"given": "R", "family": "Berger", "sequence": "first", "affiliation": []}, {"name": "on behalf of the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)", "sequence": "first", "affiliation": []}, {"given": "N", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Busson", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "van den Akker", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "P\u00e9rot", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Ballerini", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Michaux", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Charrin", "sequence": "additional", "affiliation": []}, {"given": "M P", "family": "Pages", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Mugneret", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Andrieux", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Talmant", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "H\u00e9lias", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Mauvieux", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Lafage-Pochitaloff", "sequence": "additional", "affiliation": []}, {"given": "M-J", "family": "Mozziconacci", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Cornillet-Lefebvre", "sequence": "additional", "affiliation": []}, {"given": "I", "family": "Radford", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Asnafi", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Bilhou-Nabera", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Nguyen Khac", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "L\u00e9onard", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Speleman", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Bastard", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Taviaux", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Quilichini", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Herens", "sequence": "additional", "affiliation": []}, {"given": "M-J", "family": "Gr\u00e9goire", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Cav\u00e9", "sequence": "additional", "affiliation": []}, {"given": "O A", "family": "Bernard", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2003, 9, 10]]}, "reference": [{"key": "BF2403061_CR1", "first-page": "3662", "volume": "85", "author": "SP Romana", "year": "1995", "unstructured": "Romana SP, Mauchauff\u00e9 M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662\u20133670.", "journal-title": "Blood"}, {"key": "BF2403061_CR2", "first-page": "773", "volume": "94", "author": "RJ Jaju", "year": "1999", "unstructured": "Jaju RJ, Haas OA, Neat M, Harbott J, Saha V, Boultwood J et al. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. Blood 1999; 94: 773\u2013780.", "journal-title": "Blood"}, {"key": "BF2403061_CR3", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1038/sj.leu.2402249", "volume": "15", "author": "OA Bernard", "year": "2001", "unstructured": "Bernard OA, Busson-Le Coniat M, Ballerini P, Mauchauff\u00e9 M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495\u20131504.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR4", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1038/sj.leu.2402347", "volume": "16", "author": "C H\u00e9lias", "year": "2002", "unstructured": "H\u00e9lias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Aurich-Costa J et al. Translocation t(5;14)(q35;q32) in 3 cases of childhood T-cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality. Leukemia 2002; 16: 7\u201312.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR5", "first-page": "2996", "volume": "78", "author": "ID Dub\u00e9", "year": "1991", "unstructured": "Dub\u00e9 ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G et al. A novel homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood 1991; 78: 2996\u20133003.", "journal-title": "Blood"}, {"key": "BF2403061_CR6", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1126/science.1676542", "volume": "253", "author": "M Hatano", "year": "1991", "unstructured": "Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ . Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991; 253: 79\u201382.", "journal-title": "Science"}, {"key": "BF2403061_CR7", "doi-asserted-by": "publisher", "first-page": "2257", "DOI": "10.1038/sj.leu.2401960", "volume": "14", "author": "E Vilmer", "year": "2000", "unstructured": "Vilmer E, Suciu S, Ferster A, Bertrand Y, Cav\u00e9 H, Thyss A et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 2000; 14: 2257\u20132266.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR8", "doi-asserted-by": "publisher", "first-page": "1617", "DOI": "10.1054/bjoc.2000.1504", "volume": "83", "author": "J Donadieu", "year": "2000", "unstructured": "Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J et al. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer 2000; 83: 1617\u20131622.", "journal-title": "Br J Cancer"}, {"key": "BF2403061_CR9", "doi-asserted-by": "publisher", "first-page": "2057", "DOI": "10.1182/blood-2002-03-0704", "volume": "100", "author": "H Dombret", "year": "2002", "unstructured": "Dombret H, Gabert J, Boiron J-M, Rigal-Huret F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia \u2013 results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2057\u20132066.", "journal-title": "Blood"}, {"key": "BF2403061_CR10", "first-page": "1783", "volume": "9", "author": "MC Bene", "year": "1995", "unstructured": "European Group for the Immunological Characterization of Leukemias. (EGIL): Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783\u20131786.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR11", "unstructured": "ISCN 1995. An International System for Human Cytogenetic Nomenclature. In: Mitelman F (ed). Basel, Switzerland: Karger, 1995."}, {"key": "BF2403061_CR12", "doi-asserted-by": "publisher", "first-page": "991", "DOI": "10.1182/blood-2001-11-0093", "volume": "100", "author": "P Ballerini", "year": "2002", "unstructured": "Ballerini P, Blaise A, Busson-Le Coniat M, Su X-Y, Zucman-Rossi J, Adam M et al. Hox11L2 expression defines a clinical subtype of pediatrc T-ALL associated with poor prognostic. Blood 2002; 100: 991\u2013997.", "journal-title": "Blood"}, {"key": "BF2403061_CR13", "doi-asserted-by": "publisher", "first-page": "2417", "DOI": "10.1038/sj.leu.2402709", "volume": "16", "author": "L Mauvieux", "year": "2002", "unstructured": "Mauvieux L, Leymarie V, Helias C, Perusson N, Falkenrodt A, Lioure B et al. High incidence of HOX11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417\u20132422.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR14", "first-page": "1539", "volume": "8", "author": "JA Whitlock", "year": "1994", "unstructured": "Whitlock JA, Raimondi SC, Harbott J, Morris SW, McCurley TL, Hansen-Hagge TE et al. t(5;14)(q33-34;q11), a new recurring cytogenetic abnormality in childhood acute leukemia. Leukemia 1994; 8: 1539\u20131543.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR15", "first-page": "22205", "volume": "16", "author": "TE Hansen-Haage", "year": "2002", "unstructured": "Hansen-Haage TE, Sch\u00e4fer M, Kiyoi H, Morris SW, Whitlock JA, Koch P et al. Disruption of the RanbBP17/Hox11L2 region by recombination with the TCRd locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 2002; 16: 22205\u201322212.", "journal-title": "Leukemia"}, {"key": "BF2403061_CR16", "first-page": "1760", "volume": "93", "author": "CG Begley", "year": "1999", "unstructured": "Begley CG, Green AR . The SCL gene: from case report to critical hematopoietic regulator. Blood 1999; 93: 1760\u20131770.", "journal-title": "Blood"}, {"key": "BF2403061_CR17", "first-page": "1917", "volume": "55", "author": "PD Aplan", "year": "1995", "unstructured": "Aplan PD, Johnson BE, Russell E, Chervinsky DS, Kirsch IR . Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res 1995; 55: 1917\u20131921.", "journal-title": "Cancer Res"}, {"key": "BF2403061_CR18", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/S1535-6108(02)00018-1", "volume": "1", "author": "AA Ferrando", "year": "2002", "unstructured": "Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75\u201387.", "journal-title": "Cancer Cell"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2403061.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403061", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403061.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T06:20:57Z", "timestamp": 1552803657000}, "score": 42.887558, "issued": {"date-parts": [[2003, 9]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[2003, 9]]}, "issue": "9"}, "alternative-id": ["BF2403061"], "URL": "http://dx.doi.org/10.1038/sj.leu.2403061", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T23:46:21Z", "timestamp": 1574207181122}, "reference-count": 8, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 2, 1]], "date-time": "2007-02-01T00:00:00Z", "timestamp": 1170288000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pathologie Biologie"], "published-print": {"date-parts": [[2007, 2]]}, "DOI": "10.1016/j.patbio.2006.04.004", "type": "journal-article", "created": {"date-parts": [[2006, 5, 12]], "date-time": "2006-05-12T15:16:36Z", "timestamp": 1147446996000}, "page": "56-58", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Interleukin-2\u00a0receptor beta chain locus rearrangement in\u00a0a\u00a0T-cell acute lymphoblastic leukemia"], "prefix": "10.1016", "volume": "55", "author": [{"given": "R.", "family": "Berger", "sequence": "first", "affiliation": []}, {"given": "O.A.", "family": "Bernard", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pathologie Biologie"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0369811406000654?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0369811406000654?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T20:55:42Z", "timestamp": 1555620942000}, "score": 34.028202, "issued": {"date-parts": [[2007, 2]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2007, 2]]}, "issue": "1"}, "alternative-id": ["S0369811406000654"], "URL": "http://dx.doi.org/10.1016/j.patbio.2006.04.004", "ISSN": ["0369-8114"], "issn-type": [{"value": "0369-8114", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:12:31Z", "timestamp": 1575159151411}, "reference-count": 9, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 6, 30]], "date-time": "2005-06-30T00:00:00Z", "timestamp": 1120089600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2005, 9]]}, "DOI": "10.1038/sj.leu.2403834", "type": "journal-article", "created": {"date-parts": [[2005, 6, 30]], "date-time": "2005-06-30T15:27:54Z", "timestamp": 1120145274000}, "page": "1705-1708", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols"], "prefix": "10.1038", "volume": "19", "author": [{"given": "N G", "family": "Gottardo", "sequence": "first", "affiliation": []}, {"given": "P A", "family": "Jacoby", "sequence": "additional", "affiliation": []}, {"given": "H N", "family": "Sather", "sequence": "additional", "affiliation": []}, {"given": "G H", "family": "Reaman", "sequence": "additional", "affiliation": []}, {"given": "D L", "family": "Baker", "sequence": "additional", "affiliation": []}, {"given": "U R", "family": "Kees", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 6, 30]]}, "reference": [{"key": "BF2403834_CR1", "doi-asserted-by": "publisher", "first-page": "1270", "DOI": "10.1200/JCO.1998.16.4.1270", "volume": "16", "author": "NA Heerema", "year": "1998", "unstructured": "Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. JCO 1998; 16: 1270\u20131278.", "journal-title": "JCO"}, {"key": "BF2403834_CR2", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1038/sj.leu.2402249", "volume": "15", "author": "OA Bernard", "year": "2001", "unstructured": "Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauff\u00e9 M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the HOX11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495\u20131504.", "journal-title": "Leukemia"}, {"key": "BF2403834_CR3", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1016/S0140-6736(04)15542-6", "volume": "363", "author": "AA Ferrando", "year": "2004", "unstructured": "Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukemia. Lancet 2004; 363: 535\u2013536.", "journal-title": "Lancet"}, {"key": "BF2403834_CR4", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/S1535-6108(02)00018-1", "volume": "1", "author": "AA Ferrando", "year": "2002", "unstructured": "Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75\u201387.", "journal-title": "Cancer Cell"}, {"key": "BF2403834_CR5", "doi-asserted-by": "publisher", "first-page": "887", "DOI": "10.1038/sj.leu.2402892", "volume": "17", "author": "UR Kees", "year": "2003", "unstructured": "Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK et al. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG). Leukemia 2003; 17: 887\u2013893.", "journal-title": "Leukemia"}, {"key": "BF2403834_CR6", "doi-asserted-by": "publisher", "first-page": "991", "DOI": "10.1182/blood-2001-11-0093", "volume": "100", "author": "P Ballerini", "year": "2002", "unstructured": "Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002; 100: 991\u2013997.", "journal-title": "Blood"}, {"key": "BF2403834_CR7", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1182/blood-2003-05-1495", "volume": "103", "author": "H Cav\u00e9", "year": "2004", "unstructured": "Cav\u00e9 H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A et al., for the EORTC-CLG. Clinical significance of HOX11L2 expression linked to t(5:14)(q35:q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004; 103: 442\u2013450.", "journal-title": "Blood"}, {"key": "BF2403834_CR8", "doi-asserted-by": "publisher", "first-page": "2693", "DOI": "10.1182/blood-2002-08-2438", "volume": "101", "author": "V Asnafi", "year": "2003", "unstructured": "Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne M et al. Analysis of TCR, pT\u03b1, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003; 101: 2693\u20132703.", "journal-title": "Blood"}, {"key": "BF2403834_CR9", "doi-asserted-by": "publisher", "first-page": "1851", "DOI": "10.1038/sj.leu.2403061", "volume": "17", "author": "R Berger", "year": "2003", "unstructured": "Berger R, Dastugue N, Busson M, van den Akker J, P\u00e9rot C, Ballerini P, et al., on behalf of the Groupe Francais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH). t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH). Leukemia 2003; 17: 1851\u20131857.", "journal-title": "Leukemia"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2403834.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403834", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403834.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T10:38:16Z", "timestamp": 1552732696000}, "score": 33.64513, "issued": {"date-parts": [[2005, 6, 30]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2005, 9]]}, "issue": "9"}, "alternative-id": ["BF2403834"], "URL": "http://dx.doi.org/10.1038/sj.leu.2403834", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:24:36Z", "timestamp": 1574479476601}, "publisher-location": "Totowa, NJ", "reference-count": 115, "publisher": "Humana Press", "isbn-type": [{"value": "9781607617068", "type": "print"}, {"value": "9781607617075", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-1-60761-707-5_12", "type": "book-chapter", "created": {"date-parts": [[2010, 11, 17]], "date-time": "2010-11-17T18:44:45Z", "timestamp": 1290019485000}, "page": "157-174", "source": "Crossref", "is-referenced-by-count": 0, "title": ["T-Cell Acute Lymphoblastic Leukemia"], "prefix": "10.1007", "author": [{"given": "Andrei R.", "family": "Shustov", "sequence": "first", "affiliation": []}, {"given": "Frederick R.", "family": "Appelbaum", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 10, 19]]}, "reference": [{"issue": "10", "key": "12_CR1_12", "first-page": "1783", "volume": "9", "author": "MC Bene", "year": "1995", "unstructured": "Bene, M. C., Castoldi, G., Knapp, W., Ludwig, W. D., Matutes, E., Orfao, A., et al. (1995). Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia, 9(10), 1783\u20131786.", "journal-title": "Leukemia"}, {"issue": "7", "key": "12_CR2_12", "doi-asserted-by": "publisher", "first-page": "2693", "DOI": "10.1182/blood-2002-08-2438", "volume": "101", "author": "V Asnafi", "year": "2003", "unstructured": "Asnafi, V., Beldjord, K., Boulanger, E., Comba, B., Le Tutour, P., Estienne, M. H., et al. (2003). Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood, 101(7), 2693\u20132703.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR3_12", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1046/j.1468-0734.2002.00069.x", "volume": "6", "author": "CJ Harrison", "year": "2002", "unstructured": "Harrison, C. J., & Foroni, L. (2002). Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology, 6(2), 91\u2013113. discussion 200-2.", "journal-title": "Reviews in Clinical and Experimental Hematology"}, {"issue": "1", "key": "12_CR4_12", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1182/blood-2002-10-3221", "volume": "102", "author": "AA Ferrando", "year": "2003", "unstructured": "Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., et al. (2003). Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation. Blood, 102(1), 262\u2013268.", "journal-title": "Blood"}, {"issue": "1", "key": "12_CR5_12", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/S1535-6108(02)00018-1", "volume": "1", "author": "AA Ferrando", "year": "2002", "unstructured": "Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., et al. (2002). Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1(1), 75\u201387.", "journal-title": "Cancer Cell"}, {"issue": "1", "key": "12_CR6_12", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1182/blood-2004-10-3900", "volume": "106", "author": "J Soulier", "year": "2005", "unstructured": "Soulier, J., Clappier, E., Cayuela, J. M., Regnault, A., Garcia-Peydro, M., Dombret, H., et al. (2005). HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood, 106(1), 274\u2013286.", "journal-title": "Blood"}, {"issue": "5694", "key": "12_CR7_12", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1126/science.1102160", "volume": "306", "author": "AP Weng", "year": "2004", "unstructured": "Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., 4th, Silverman, L. B., Sanchez-Irizarry, C., et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306(5694), 269\u2013271.", "journal-title": "Science"}, {"issue": "9", "key": "12_CR8_12", "doi-asserted-by": "publisher", "first-page": "1496", "DOI": "10.1038/sj.leu.2404302", "volume": "20", "author": "C Graux", "year": "2006", "unstructured": "Graux, C., Cools, J., Michaux, L., Vandenberghe, P., & Hagemeijer, A. (2006). Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: From thymocyte to lymphoblast. Leukemia, 20(9), 1496\u20131510.", "journal-title": "Leukemia"}, {"issue": "7", "key": "12_CR9_12", "doi-asserted-by": "publisher", "first-page": "1238", "DOI": "10.1038/sj.leu.2404243", "volume": "20", "author": "B Cauwelier", "year": "2006", "unstructured": "Cauwelier, B., Dastugue, N., Cools, J., Poppe, B., Herens, C., De Paepe, A., et al. (2006). Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes. Leukemia, 20(7), 1238\u20131244.", "journal-title": "Leukemia"}, {"issue": "10", "key": "12_CR10_12", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1038/sj.leu.2402249", "volume": "15", "author": "OA Bernard", "year": "2001", "unstructured": "Bernard, O. A., Busson-LeConiat, M., Ballerini, P., Mauchauffe, M., Della Valle, V., Monni, R., et al. (2001). A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia, 15(10), 1495\u20131504.", "journal-title": "Leukemia"}, {"issue": "3", "key": "12_CR11_12", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1038/sj.leu.2400596", "volume": "11", "author": "A Iolascon", "year": "1997", "unstructured": "Iolascon, A., Faienza, M. F., Coppola, B., Moretti, A., Basso, G., Amaru, R., et al. (1997). Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene. Leukemia, 11(3), 359\u2013363.", "journal-title": "Leukemia"}, {"issue": "7", "key": "12_CR12_12", "doi-asserted-by": "publisher", "first-page": "2324", "DOI": "10.1182/blood-2007-04-079988", "volume": "110", "author": "J Bergeron", "year": "2007", "unstructured": "Bergeron, J., Clappier, E., Radford, I., Buzyn, A., Millien, C., Soler, G., et al. (2007). Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs. Blood, 110(7), 2324\u20132330.", "journal-title": "Blood"}, {"issue": "9408", "key": "12_CR13_12", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1016/S0140-6736(04)15542-6", "volume": "363", "author": "AA Ferrando", "year": "2004", "unstructured": "Ferrando, A. A., Neuberg, D. S., Dodge, R. K., Paietta, E., Larson, R. A., Wiernik, P. H., et al. (2004). Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet, 363(9408), 535\u2013536.", "journal-title": "Lancet"}, {"issue": "3", "key": "12_CR14_12", "doi-asserted-by": "publisher", "first-page": "1000", "DOI": "10.1182/blood-2002-09-2913", "volume": "102", "author": "V Asnafi", "year": "2003", "unstructured": "Asnafi, V., Radford-Weiss, I., Dastugue, N., Bayle, C., Leboeuf, D., Charrin, C., et al. (2003). CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood, 102(3), 1000\u20131006.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR15_12", "doi-asserted-by": "publisher", "first-page": "4647", "DOI": "10.1182/blood-2002-03-0717", "volume": "99", "author": "S Hayette", "year": "2002", "unstructured": "Hayette, S., Tigaud, I., Maguer-Satta, V., Bartholin, L., Thomas, X., Charrin, C., et al. (2002). Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood, 99(12), 4647\u20134649.", "journal-title": "Blood"}, {"issue": "1", "key": "12_CR16_12", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1200/JCO.1999.17.1.191", "volume": "17", "author": "JE Rubnitz", "year": "1999", "unstructured": "Rubnitz, J. E., Camitta, B. M., Mahmoud, H., Raimondi, S. C., Carroll, A. J., Borowitz, M. J., et al. (1999). Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. Journal of Clinical Oncology, 17(1), 191\u2013196.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "16", "key": "12_CR17_12", "first-page": "4882", "volume": "63", "author": "S Tsutsumi", "year": "2003", "unstructured": "Tsutsumi, S., Taketani, T., Nishimura, K., Ge, X., Taki, T., Sugita, K., et al. (2003). Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Research, 63(16), 4882\u20134887.", "journal-title": "Cancer Research"}, {"issue": "10", "key": "12_CR18_12", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.1038/ng1425", "volume": "36", "author": "C Graux", "year": "2004", "unstructured": "Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A., Levine, R., et al. (2004). Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nature Genetics, 36(10), 1084\u20131089.", "journal-title": "Nature Genetics"}, {"key": "12_CR19_12", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1038/leu.2008.278", "volume": "23", "author": "C Graux", "year": "2009", "unstructured": "Graux, C., Stevens-Kroef, M., Lafage, M., Dastugue, N., Harrison, C. J., Mugneret, F., et al. (2009). Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia, 23, 125\u2013133.", "journal-title": "Leukemia"}, {"issue": "12", "key": "12_CR20_12", "first-page": "4038", "volume": "84", "author": "J Hebert", "year": "1994", "unstructured": "Hebert, J., Cayuela, J. M., Berkeley, J., & Sigaux, F. (1994). Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84(12), 4038\u20134044.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR21_12", "doi-asserted-by": "publisher", "first-page": "4089", "DOI": "10.1158/0008-5472.CAN-03-1871", "volume": "64", "author": "PB Sinclair", "year": "2004", "unstructured": "Sinclair, P. B., Sorour, A., Martineau, M., Harrison, C. J., Mitchell, W. A., O\u2019Neill, E., et al. (2004). A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. Cancer Research, 64(12), 4089\u20134098.", "journal-title": "Cancer Research"}, {"issue": "6", "key": "12_CR22_12", "doi-asserted-by": "publisher", "first-page": "2540", "DOI": "10.1182/blood-2005-07-3013", "volume": "107", "author": "YW Lin", "year": "2006", "unstructured": "Lin, Y. W., Nichols, R. A., Letterio, J. J., & Aplan, P. D. (2006). Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood, 107(6), 2540\u20132543.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR23_12", "doi-asserted-by": "publisher", "first-page": "781", "DOI": "10.1182/blood-2005-06-2553", "volume": "107", "author": "J O\u2019Neil", "year": "2006", "unstructured": "O\u2019Neil, J., Calvo, J., McKenna, K., Krishnamoorthy, V., Aster, J. C., Bassing, C. H., et al. (2006). Activating Notch1 mutations in mouse models of T-ALL. Blood, 107(2), 781\u2013785.", "journal-title": "Blood"}, {"issue": "1", "key": "12_CR24_12", "doi-asserted-by": "publisher", "first-page": "376", "DOI": "10.1182/blood-2007-02-074690", "volume": "111", "author": "M Eguchi-Ishimae", "year": "2008", "unstructured": "Eguchi-Ishimae, M., Eguchi, M., Kempski, H., & Greaves, M. (2008). NOTCH1 mutation can be an early, prenatal genetic event in T-ALL. Blood, 111(1), 376\u2013378.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR25_12", "doi-asserted-by": "publisher", "first-page": "655", "DOI": "10.1128/MCB.23.2.655-664.2003", "volume": "23", "author": "AP Weng", "year": "2003", "unstructured": "Weng, A. P., Nam, Y., Wolfe, M. S., Pear, W. S., Griffin, J. D., Blacklow, S. C., et al. (2003). Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Molecular and Cellular Biology, 23(2), 655\u2013664.", "journal-title": "Molecular and Cellular Biology"}, {"issue": "7", "key": "12_CR26_12", "doi-asserted-by": "publisher", "first-page": "2444", "DOI": "10.1182/blood-2002-10-3261", "volume": "102", "author": "M Garcia-Peydro", "year": "2003", "unstructured": "Garcia-Peydro, M., de Yebenes, V. G., & Toribio, M. L. (2003). Sustained Notch1 signaling instructs the earliest human intrathymic precursors to adopt a gammadelta T-cell fate in fetal thymus organ culture. Blood, 102(7), 2444\u20132451.", "journal-title": "Blood"}, {"issue": "5", "key": "12_CR27_12", "doi-asserted-by": "publisher", "first-page": "547", "DOI": "10.1016/S1074-7613(00)80054-0", "volume": "10", "author": "F Radtke", "year": "1999", "unstructured": "Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H. R., et al. (1999). Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity, 10(5), 547\u2013558.", "journal-title": "Immunity"}, {"issue": "9", "key": "12_CR28_12", "doi-asserted-by": "crossref", "first-page": "5230", "DOI": "10.4049/jimmunol.172.9.5230", "volume": "172", "author": "M Ciofani", "year": "2004", "unstructured": "Ciofani, M., Schmitt, T. M., Ciofani, A., Michie, A. M., Cuburu, N., Aublin, A., et al. (2004). Obligatory role for cooperative signaling by pre-TCR and notch during thymocyte differentiation. Journal of Immunology, 172(9), 5230\u20135239.", "journal-title": "Journal of Immunology"}, {"issue": "6", "key": "12_CR29_12", "doi-asserted-by": "publisher", "first-page": "869", "DOI": "10.1016/S1074-7613(02)00330-8", "volume": "16", "author": "A Wolfer", "year": "2002", "unstructured": "Wolfer, A., Wilson, A., Nemir, M., MacDonald, H. R., & Radtke, F. (2002). Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity, 16(6), 869\u2013879.", "journal-title": "Immunity"}, {"issue": "21", "key": "12_CR30_12", "doi-asserted-by": "publisher", "first-page": "5780", "DOI": "10.1093/emboj/cdg567", "volume": "22", "author": "L Nie", "year": "2003", "unstructured": "Nie, L., Xu, M., Vladimirova, A., & Sun, X. H. (2003). Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. The EMBO Journal, 22(21), 5780\u20135792.", "journal-title": "The EMBO Journal"}, {"issue": "3", "key": "12_CR31_12", "doi-asserted-by": "crossref", "first-page": "R129", "DOI": "10.1016/j.cub.2004.01.023", "volume": "14", "author": "F Schweisguth", "year": "2004", "unstructured": "Schweisguth, F. (2004). Regulation of notch signaling activity. Current Biology, 14(3), R129\u2013R138.", "journal-title": "Current Biology"}, {"issue": "5", "key": "12_CR32_12", "doi-asserted-by": "publisher", "first-page": "2283", "DOI": "10.1084/jem.183.5.2283", "volume": "183", "author": "WS Pear", "year": "1996", "unstructured": "Pear, W. S., Aster, J. C., Scott, M. L., Hasserjian, R. P., Soffer, B., Sklar, J., et al. (1996). Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated notch alleles. The Journal of Experimental Medicine, 183(5), 2283\u20132291.", "journal-title": "The Journal of Experimental Medicine"}, {"issue": "5", "key": "12_CR33_12", "doi-asserted-by": "publisher", "first-page": "2878", "DOI": "10.1182/blood-2007-07-103119", "volume": "111", "author": "SF Wang", "year": "2008", "unstructured": "Wang, S. F., Aoki, M., Nakashima, Y., Shinozuka, Y., Tanaka, H., Taniwaki, M., et al. (2008). Development of notch-dependent T-cell leukemia by deregulated Rap1 signaling. Blood, 111(5), 2878\u20132886.", "journal-title": "Blood"}, {"issue": "4", "key": "12_CR34_12", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1532/IJH97.05096", "volume": "82", "author": "JC Aster", "year": "2005", "unstructured": "Aster, J. C. (2005). Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: New insights, questions, and opportunities. International Journal of Hematology, 82(4), 295\u2013301.", "journal-title": "International Journal of Hematology"}, {"issue": "3", "key": "12_CR35_12", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1038/ni1164", "volume": "6", "author": "AW Duncan", "year": "2005", "unstructured": "Duncan, A. W., Rattis, F. M., DiMascio, L. N., Congdon, K. L., Pazianos, G., Zhao, C., et al. (2005). Integration of notch and Wnt signaling in hematopoietic stem cell maintenance. Nature Immunology, 6(3), 314\u2013322.", "journal-title": "Nature Immunology"}, {"issue": "1", "key": "12_CR36_12", "doi-asserted-by": "publisher", "first-page": "278", "DOI": "10.1182/blood-2006-08-039883", "volume": "110", "author": "SM Chan", "year": "2007", "unstructured": "Chan, S. M., Weng, A. P., Tibshirani, R., Aster, J. C., & Utz, P. J. (2007). Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood, 110(1), 278\u2013286.", "journal-title": "Blood"}, {"key": "12_CR37_12", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1146/annurev.immunol.22.012703.104753", "volume": "22", "author": "S Wong", "year": "2004", "unstructured": "Wong, S., & Witte, O. N. (2004). The BCR-ABL story: Bench to bedside and back. Annual Review of Immunology, 22, 247\u2013306.", "journal-title": "Annual Review of Immunology"}, {"issue": "15", "key": "12_CR38_12", "doi-asserted-by": "publisher", "first-page": "1535", "DOI": "10.1056/NEJMra023001", "volume": "350", "author": "CH Pui", "year": "2004", "unstructured": "Pui, C. H., Relling, M. V., & Downing, J. R. (2004). Acute lymphoblastic leukemia. The New England Journal of Medicine, 350(15), 1535\u20131548.", "journal-title": "The New England Journal of Medicine"}, {"issue": "2", "key": "12_CR39_12", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1038/sj.leu.2403595", "volume": "19", "author": "H Quentmeier", "year": "2005", "unstructured": "Quentmeier, H., Cools, J., Macleod, R. A., Marynen, P., Uphoff, C. C., & Drexler, H. G. (2005). e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia. Leukemia, 19(2), 295\u2013296.", "journal-title": "Leukemia"}, {"issue": "3", "key": "12_CR40_12", "doi-asserted-by": "publisher", "first-page": "468", "DOI": "10.1038/sj.leu.2403654", "volume": "19", "author": "P Ballerini", "year": "2005", "unstructured": "Ballerini, P., Busson, M., Fasola, S., van den Akker, J., Lapillonne, H., Romana, S. P., et al. (2005). NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance. Leukemia, 19(3), 468\u2013470.", "journal-title": "Leukemia"}, {"issue": "12", "key": "12_CR41_12", "doi-asserted-by": "publisher", "first-page": "4849", "DOI": "10.1182/blood-2004-12-4897", "volume": "105", "author": "K Keersmaecker De", "year": "2005", "unstructured": "De Keersmaecker, K., Graux, C., Odero, M. D., Mentens, N., Somers, R., Maertens, J., et al. (2005). Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood, 105(12), 4849\u20134852.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR42_12", "doi-asserted-by": "publisher", "first-page": "2202", "DOI": "10.1038/sj.leu.2404425", "volume": "20", "author": "K Keersmaecker De", "year": "2006", "unstructured": "De Keersmaecker, K., Lahortiga, I., Graux, C., Marynen, P., Maertens, J., Cools, J., et al. (2006). Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia. Leukemia, 20(12), 2202\u20132204.", "journal-title": "Leukemia"}, {"issue": "14", "key": "12_CR43_12", "doi-asserted-by": "publisher", "first-page": "1222", "DOI": "10.1016/j.cub.2004.07.021", "volume": "14", "author": "PA Zipfel", "year": "2004", "unstructured": "Zipfel, P. A., Zhang, W., Quiroz, M., & Pendergast, A. M. (2004). Requirement for Abl kinases in T cell receptor signaling. Current Biology, 14(14), 1222\u20131231.", "journal-title": "Current Biology"}, {"issue": "6", "key": "12_CR44_12", "first-page": "1603", "volume": "83", "author": "A Neubauer", "year": "1994", "unstructured": "Neubauer, A., Dodge, R. K., George, S. L., Davey, F. R., Silver, R. T., Schiffer, C. A., et al. (1994). Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood, 83(6), 1603\u20131611.", "journal-title": "Blood"}, {"issue": "4", "key": "12_CR45_12", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1016/S0925-5710(98)00015-2", "volume": "67", "author": "S Yokota", "year": "1998", "unstructured": "Yokota, S., Nakao, M., Horiike, S., Seriu, T., Iwai, T., Kaneko, H., et al. (1998). Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: A study of 125 Japanese pediatric cases. International Journal of Hematology, 67(4), 379\u2013387.", "journal-title": "International Journal of Hematology"}, {"issue": "5", "key": "12_CR46_12", "first-page": "1804", "volume": "6", "author": "FC Lintig von", "year": "2000", "unstructured": "von Lintig, F. C., Huvar, I., Law, P., Diccianni, M. B., Yu, A. L., & Boss, G. R. (2000). Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clinical Cancer Research, 6(5), 1804\u20131810.", "journal-title": "Clinical Cancer Research"}, {"issue": "10", "key": "12_CR47_12", "doi-asserted-by": "publisher", "first-page": "3532", "DOI": "10.1182/blood-2005-04-1640", "volume": "106", "author": "BF Goemans", "year": "2005", "unstructured": "Goemans, B. F., Zwaan, C. M., Harlow, A., Loonen, A. H., Gibson, B. E., Hahlen, K., et al. (2005). In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: Identification of T-cell ALL and FAB M5 AML as the most sensitive subsets. Blood, 106(10), 3532\u20133537.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR48_12", "doi-asserted-by": "publisher", "first-page": "558", "DOI": "10.1182/blood-2004-01-0168", "volume": "104", "author": "E Paietta", "year": "2004", "unstructured": "Paietta, E., Ferrando, A. A., Neuberg, D., Bennett, J. M., Racevskis, J., Lazarus, H., et al. (2004). Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood, 104(2), 558\u2013560.", "journal-title": "Blood"}, {"issue": "7", "key": "12_CR49_12", "first-page": "2535", "volume": "90", "author": "P Peeters", "year": "1997", "unstructured": "Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., et al. (1997). Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood, 90(7), 2535\u20132540.", "journal-title": "Blood"}, {"issue": "13", "key": "12_CR50_12", "doi-asserted-by": "publisher", "first-page": "4414", "DOI": "10.1182/blood-2005-06-2267", "volume": "106", "author": "P Vlierberghe Van", "year": "2005", "unstructured": "Van Vlierberghe, P., Meijerink, J. P., Stam, R. W., van der Smissen, W., van Wering, E. R., Beverloo, H. B., et al. (2005). Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias. Blood, 106(13), 4414\u20134415.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR51_12", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1056/NEJMra052603", "volume": "354", "author": "CH Pui", "year": "2006", "unstructured": "Pui, C. H., & Evans, W. E. (2006). Treatment of acute lymphoblastic leukemia. The New England Journal of Medicine, 354(2), 166\u2013178.", "journal-title": "The New England Journal of Medicine"}, {"issue": "9", "key": "12_CR52_12", "doi-asserted-by": "publisher", "first-page": "2690", "DOI": "10.1182/blood-2004-04-1616", "volume": "104", "author": "CH Pui", "year": "2004", "unstructured": "Pui, C. H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., et al. (2004). Improved outcome for children with acute lymphoblastic leukemia: Results of total therapy study XIIIB at St Jude Children\u2019s Research hospital. Blood, 104(9), 2690\u20132696.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR53_12", "doi-asserted-by": "publisher", "first-page": "3760", "DOI": "10.1182/blood-2005-04-1623", "volume": "106", "author": "JM Rowe", "year": "2005", "unstructured": "Rowe, J. M., Buck, G., Burnett, A. K., Chopra, R., Wiernik, P. H., Richards, S. M., et al. (2005). Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106(12), 3760\u20133767.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR54_12", "doi-asserted-by": "publisher", "first-page": "2196", "DOI": "10.1038/sj.leu.2401963", "volume": "14", "author": "V Conter", "year": "2000", "unstructured": "Conter, V., Arico, M., Valsecchi, M. G., Basso, G., Biondi, A., Madon, E., et al. (2000). Long-term results of the Italian association of pediatric hematology and oncology (AIEOP) acute lymphoblastic leukemia studies, 1982\u20131995. Leukemia, 14(12), 2196\u20132204.", "journal-title": "Leukemia"}, {"issue": "6", "key": "12_CR55_12", "doi-asserted-by": "publisher", "first-page": "1099", "DOI": "10.1038/sj.leu.2402489", "volume": "16", "author": "WA Kamps", "year": "2002", "unstructured": "Kamps, W. A., Bokkerink, J. P., Hakvoort-Cammel, F. G., Veerman, A. J., Weening, R. S., van Wering, E. R., et al. (2002). BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: Results of DCLSG protocol ALL-8 (1991\u20131996). Leukemia, 16(6), 1099\u20131111.", "journal-title": "Leukemia"}, {"issue": "5", "key": "12_CR56_12", "doi-asserted-by": "publisher", "first-page": "1211", "DOI": "10.1182/blood.V97.5.1211", "volume": "97", "author": "LB Silverman", "year": "2001", "unstructured": "Silverman, L. B., Gelber, R. D., Dalton, V. K., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2001). Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber consortium protocol 91-01. Blood, 97(5), 1211\u20131218.", "journal-title": "Blood"}, {"issue": "3", "key": "12_CR57_12", "doi-asserted-by": "publisher", "first-page": "991", "DOI": "10.1182/blood-2001-11-0093", "volume": "100", "author": "P Ballerini", "year": "2002", "unstructured": "Ballerini, P., Blaise, A., Busson-Le Coniat, M., Su, X. Y., Zucman-Rossi, J., Adam, M., et al. (2002). HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood, 100(3), 991\u2013997.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR58_12", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1182/blood-2003-05-1495", "volume": "103", "author": "H Cave", "year": "2004", "unstructured": "Cave, H., Suciu, S., Preudhomme, C., Poppe, B., Robert, A., Uyttebroeck, A., et al. (2004). Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: Results of EORTC studies 58881 and 58951. Blood, 103(2), 442\u2013450.", "journal-title": "Blood"}, {"issue": "8", "key": "12_CR59_12", "doi-asserted-by": "publisher", "first-page": "1422", "DOI": "10.1038/sj.leu.2404275", "volume": "20", "author": "B Burkhardt", "year": "2006", "unstructured": "Burkhardt, B., Bruch, J., Zimmermann, M., Strauch, K., Parwaresch, R., Ludwig, W. D., et al. (2006). Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia, 20(8), 1422\u20131429.", "journal-title": "Leukemia"}, {"issue": "3", "key": "12_CR60_12", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1080/10428190701824551", "volume": "49", "author": "B Burkhardt", "year": "2008", "unstructured": "Burkhardt, B., Moericke, A., Klapper, W., Greene, F., Salzburg, J., Damm-Welk, C., et al. (2008). Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leukaemia & Lymphoma, 49(3), 451\u2013461.", "journal-title": "Leukaemia & Lymphoma"}, {"issue": "9321", "key": "12_CR61_12", "doi-asserted-by": "publisher", "first-page": "1909", "DOI": "10.1016/S0140-6736(02)08782-2", "volume": "359", "author": "CH Pui", "year": "2002", "unstructured": "Pui, C. H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., et al. (2002). Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet, 359(9321), 1909\u20131915.", "journal-title": "Lancet"}, {"issue": "26", "key": "12_CR62_12", "doi-asserted-by": "publisher", "first-page": "6306", "DOI": "10.1200/JCO.2005.05.047", "volume": "23", "author": "SA Armstrong", "year": "2005", "unstructured": "Armstrong, S. A., & Look, A. T. (2005). Molecular genetics of acute lymphoblastic leukemia. Journal of Clinical Oncology, 23(26), 6306\u20136315.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "9", "key": "12_CR63_12", "doi-asserted-by": "publisher", "first-page": "3434", "DOI": "10.1182/blood-2004-07-2922", "volume": "105", "author": "M Mancini", "year": "2005", "unstructured": "Mancini, M., Scappaticci, D., Cimino, G., Nanni, M., Derme, V., Elia, L., et al. (2005). A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): Analysis of the GIMEMA 0496 protocol. Blood, 105(9), 3434\u20133441.", "journal-title": "Blood"}, {"issue": "3", "key": "12_CR64_12", "doi-asserted-by": "publisher", "first-page": "680", "DOI": "10.1046/j.1365-2141.2001.02586.x", "volume": "112", "author": "NL Ramakers-van Woerden", "year": "2001", "unstructured": "Ramakers-van Woerden, N. L., Pieters, R., Slater, R. M., Loonen, A. H., Beverloo, H. B., van Drunen, E., et al. (2001). In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia. British Journal Haematology, 112(3), 680\u2013690.", "journal-title": "British Journal Haematology"}, {"issue": "5015", "key": "12_CR65_12", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1126/science.1676542", "volume": "253", "author": "M Hatano", "year": "1991", "unstructured": "Hatano, M., Roberts, C. W., Minden, M., Crist, W. M., & Korsmeyer, S. J. (1991). Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science, 253(5015), 79\u201382.", "journal-title": "Science"}, {"issue": "6", "key": "12_CR66_12", "first-page": "2180", "volume": "87", "author": "JM Cayuela", "year": "1996", "unstructured": "Cayuela, J. M., Madani, A., Sanhes, L., Stern, M. H., & Sigaux, F. (1996). Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood, 87(6), 2180\u20132186.", "journal-title": "Blood"}, {"issue": "6", "key": "12_CR67_12", "doi-asserted-by": "publisher", "first-page": "538", "DOI": "10.1056/NEJMra020526", "volume": "348", "author": "WE Evans", "year": "2003", "unstructured": "Evans, W. E., & McLeod, H. L. (2003). Pharmacogenomics\u2013drug disposition, drug targets, and side effects. The New England Journal of Medicine, 348(6), 538\u2013549.", "journal-title": "The New England Journal of Medicine"}, {"issue": "6990", "key": "12_CR68_12", "doi-asserted-by": "publisher", "first-page": "464", "DOI": "10.1038/nature02626", "volume": "429", "author": "WE Evans", "year": "2004", "unstructured": "Evans, W. E., & Relling, M. V. (2004). Moving towards individualized medicine with pharmacogenomics. Nature, 429(6990), 464\u2013468.", "journal-title": "Nature"}, {"issue": "9226", "key": "12_CR69_12", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1016/S0140-6736(00)02503-4", "volume": "356", "author": "MV Relling", "year": "2000", "unstructured": "Relling, M. V., Pui, C. H., Sandlund, J. T., Rivera, G. K., Hancock, M. L., Boyett, J. M., et al. (2000). Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet, 356(9226), 285\u2013290.", "journal-title": "Lancet"}, {"issue": "1", "key": "12_CR70_12", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1172/JCI22477", "volume": "115", "author": "L Kager", "year": "2005", "unstructured": "Kager, L., Cheok, M., Yang, W., Zaza, G., Cheng, Q., Panetta, J. C., et al. (2005). Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. Journal of Clinical Investigation, 115(1), 110\u2013117.", "journal-title": "Journal of Clinical Investigation"}, {"issue": "5", "key": "12_CR71_12", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1038/sj.leu.2402111", "volume": "15", "author": "CH Pui", "year": "2001", "unstructured": "Pui, C. H., Sallan, S., Relling, M. V., Masera, G., & Evans, W. E. (2001). International childhood acute lymphoblastic leukemia workshop: Sausalito, CA, 30 November\u20131 December 2000. Leukemia, 15(5), 707\u2013715.", "journal-title": "Leukemia"}, {"issue": "11", "key": "12_CR72_12", "first-page": "3310", "volume": "95", "author": "M Schrappe", "year": "2000", "unstructured": "Schrappe, M., Reiter, A., Ludwig, W. D., Harbott, J., Zimmermann, M., Hiddemann, W., et al. (2000). Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM study group. Blood, 95(11), 3310\u20133322.", "journal-title": "Blood"}, {"issue": "7", "key": "12_CR73_12", "doi-asserted-by": "publisher", "first-page": "2771", "DOI": "10.1182/blood-2003-09-3243", "volume": "103", "author": "S Chiaretti", "year": "2004", "unstructured": "Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Vignetti, M., Mandelli, F., et al. (2004). Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood, 103(7), 2771\u20132778.", "journal-title": "Blood"}, {"issue": "11", "key": "12_CR74_12", "first-page": "4288", "volume": "88", "author": "FM Uckun", "year": "1996", "unstructured": "Uckun, F. M., Steinherz, P. G., Sather, H., Trigg, M., Arthur, D., Tubergen, D., et al. (1996). CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: A children\u2019s cancer group study. Blood, 88(11), 4288\u20134295.", "journal-title": "Blood"}, {"issue": "2", "key": "12_CR75_12", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1016/S1535-6108(02)00032-6", "volume": "1", "author": "EJ Yeoh", "year": "2002", "unstructured": "Yeoh, E. J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., et al. (2002). Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1(2), 133\u2013143.", "journal-title": "Cancer Cell"}, {"issue": "9", "key": "12_CR76_12", "first-page": "3122", "volume": "84", "author": "A Reiter", "year": "1994", "unstructured": "Reiter, A., Schrappe, M., Ludwig, W. D., Hiddemann, W., Sauter, S., Henze, G., et al. (1994). Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84(9), 3122\u20133133.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR77_12", "doi-asserted-by": "publisher", "first-page": "2223", "DOI": "10.1038/sj.leu.2401939", "volume": "14", "author": "PS Gaynon", "year": "2000", "unstructured": "Gaynon, P. S., Trigg, M. E., Heerema, N. A., Sensel, M. G., Sather, H. N., Hammond, G. D., et al. (2000). Children\u2019s cancer group trials in childhood acute lymphoblastic leukemia: 1983\u20131995. Leukemia, 14(12), 2223\u20132233.", "journal-title": "Leukemia"}, {"issue": "12", "key": "12_CR78_12", "doi-asserted-by": "publisher", "first-page": "2257", "DOI": "10.1038/sj.leu.2401960", "volume": "14", "author": "E Vilmer", "year": "2000", "unstructured": "Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., et al. (2000). Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report. Children leukemia cooperative group. Leukemia, 14(12), 2257\u20132266.", "journal-title": "Leukemia"}, {"issue": "12", "key": "12_CR79_12", "doi-asserted-by": "publisher", "first-page": "2267", "DOI": "10.1038/sj.leu.2401961", "volume": "14", "author": "G Gustafsson", "year": "2000", "unstructured": "Gustafsson, G., Schmiegelow, K., Forestier, E., Clausen, N., Glomstein, A., Jonmundsson, G., et al. (2000). Improving outcome through two decades in childhood ALL in the nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic society of pediatric haematology and oncology (NOPHO). Leukemia, 14(12), 2267\u20132275.", "journal-title": "Leukemia"}, {"issue": "1", "key": "12_CR80_12", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1046/j.1365-2141.2003.04738.x", "volume": "124", "author": "FG Hill", "year": "2004", "unstructured": "Hill, F. G., Richards, S., Gibson, B., Hann, I., Lilleyman, J., Kinsey, S., et al. (2004). Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: Results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). British Journal Haematology, 124(1), 33\u201346.", "journal-title": "British Journal Haematology"}, {"issue": "12", "key": "12_CR81_12", "doi-asserted-by": "publisher", "first-page": "2788", "DOI": "10.1002/cncr.20668", "volume": "101", "author": "H Kantarjian", "year": "2004", "unstructured": "Kantarjian, H., Thomas, D., O\u2019Brien, S., Cortes, J., Giles, F., Jeha, S., et al. (2004). Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer, 101(12), 2788\u20132801.", "journal-title": "Cancer"}, {"issue": "20", "key": "12_CR82_12", "doi-asserted-by": "publisher", "first-page": "4075", "DOI": "10.1200/JCO.2004.10.050", "volume": "22", "author": "X Thomas", "year": "2004", "unstructured": "Thomas, X., Boiron, J. M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., et al. (2004). Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. Journal of Clinical Oncology, 22(20), 4075\u20134086.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "3", "key": "12_CR83_12", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1182/blood.V99.3.863", "volume": "99", "author": "L Annino", "year": "2002", "unstructured": "Annino, L., Vegna, M. L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., et al. (2002). Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood, 99(3), 863\u2013871.", "journal-title": "Blood"}, {"issue": "7", "key": "12_CR84_12", "doi-asserted-by": "publisher", "first-page": "1259", "DOI": "10.1038/sj.leu.2402526", "volume": "16", "author": "J Takeuchi", "year": "2002", "unstructured": "Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., et al. (2002). Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: The JALSG-ALL93 study. Leukemia, 16(7), 1259\u20131266.", "journal-title": "Leukemia"}, {"issue": "10", "key": "12_CR85_12", "doi-asserted-by": "publisher", "first-page": "2464", "DOI": "10.1200/JCO.2002.07.116", "volume": "20", "author": "C Linker", "year": "2002", "unstructured": "Linker, C., Damon, L., Ries, C., & Navarro, W. (2002). Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20(10), 2464\u20132471.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "5", "key": "12_CR86_12", "doi-asserted-by": "publisher", "first-page": "760", "DOI": "10.1200/JCO.2003.11.116", "volume": "21", "author": "CA Schiffer", "year": "2003", "unstructured": "Schiffer, C. A. (2003). Differences in outcome in adolescents with acute lymphoblastic leukemia: A consequence of better regimens? Better doctors? Both? Journal of Clinical Oncology, 21(5), 760\u2013761.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "12", "key": "12_CR87_12", "doi-asserted-by": "publisher", "first-page": "1811", "DOI": "10.1038/sj.leu.2402289", "volume": "15", "author": "X Thomas", "year": "2001", "unstructured": "Thomas, X., Danaila, C., Le, Q. H., Sebban, C., Troncy, J., Charrin, C., et al. (2001). Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: A single institution experience of 378 consecutive patients over a 21-year period. Leukemia, 15(12), 1811\u20131822.", "journal-title": "Leukemia"}, {"issue": "3", "key": "12_CR88_12", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1038/sj.leu.2401310", "volume": "13", "author": "MD Amylon", "year": "1999", "unstructured": "Amylon, M. D., Shuster, J., Pullen, J., Berard, C., Link, M. P., Wharam, M., et al. (1999). Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A pediatric oncology group study. Leukemia, 13(3), 335\u2013342.", "journal-title": "Leukemia"}, {"issue": "10", "key": "12_CR89_12", "doi-asserted-by": "publisher", "first-page": "4164", "DOI": "10.1182/blood-2006-09-045351", "volume": "109", "author": "M Wetzler", "year": "2007", "unstructured": "Wetzler, M., Sanford, B. L., Kurtzberg, J., DeOliveira, D., Frankel, S. R., Powell, B. L., et al. (2007). Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and leukemia group B study 9511. Blood, 109(10), 4164\u20134167.", "journal-title": "Blood"}, {"issue": "5", "key": "12_CR90_12", "doi-asserted-by": "crossref", "first-page": "1297", "DOI": "10.1200/JCO.2001.19.5.1297", "volume": "19", "author": "C Rizzari", "year": "2001", "unstructured": "Rizzari, C., Valsecchi, M. G., Arico, M., Conter, V., Testi, A., Barisone, E., et al. (2001). Effect of protracted high-dose l-asparaginase given as a second exposure in a Berlin-Frankfurt-Munster-based treatment: Results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study \u2013 A report from the Associazione Italiana Ematologia Oncologia Pediatric. Journal of Clinical Oncology, 19(5), 1297\u20131303.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "3", "key": "12_CR91_12", "doi-asserted-by": "publisher", "first-page": "896", "DOI": "10.1182/blood-2006-06-027714", "volume": "109", "author": "A Moghrabi", "year": "2007", "unstructured": "Moghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., et al. (2007). Results of the dana-farber cancer institute ALL consortium protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109(3), 896\u2013904.", "journal-title": "Blood"}, {"issue": "16", "key": "12_CR92_12", "doi-asserted-by": "publisher", "first-page": "5335", "DOI": "10.1158/1078-0432.CCR-04-0222", "volume": "10", "author": "DS Hawkins", "year": "2004", "unstructured": "Hawkins, D. S., Park, J. R., Thomson, B. G., Felgenhauer, J. L., Holcenberg, J. S., Panosyan, E. H., et al. (2004). Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated l-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clinical Cancer Research, 10(16), 5335\u20135341.", "journal-title": "Clinical Cancer Research"}, {"issue": "6", "key": "12_CR93_12", "doi-asserted-by": "publisher", "first-page": "1986", "DOI": "10.1182/blood.V99.6.1986", "volume": "99", "author": "VI Avramis", "year": "2002", "unstructured": "Avramis, V. I., Sencer, S., Periclou, A. P., Sather, H., Bostrom, B. C., Cohen, L. J., et al. (2002). A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A children\u2019s cancer group study. Blood, 99(6), 1986\u20131994.", "journal-title": "Blood"}, {"issue": "5", "key": "12_CR94_12", "first-page": "1709", "volume": "96", "author": "TC Abshire", "year": "2000", "unstructured": "Abshire, T. C., Pollock, B. H., Billett, A. L., Bradley, P., & Buchanan, G. R. (2000). Weekly polyethylene glycol conjugated l-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: A pediatric oncology group study. Blood, 96(5), 1709\u20131715.", "journal-title": "Blood"}, {"issue": "8", "key": "12_CR95_12", "doi-asserted-by": "crossref", "first-page": "2786", "DOI": "10.1200/JCO.1997.15.8.2786", "volume": "15", "author": "V Conter", "year": "1997", "unstructured": "Conter, V., Schrappe, M., Arico, M., Reiter, A., Rizzari, C., Dordelmann, M., et al. (1997). Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster groups. Journal of Clinical Oncology, 15(8), 2786\u20132791.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "10", "key": "12_CR96_12", "doi-asserted-by": "publisher", "first-page": "3028", "DOI": "10.1182/blood-2003-10-3560", "volume": "104", "author": "M Hunault", "year": "2004", "unstructured": "Hunault, M., Harousseau, J. L., Delain, M., Truchan-Graczyk, M., Cahn, J. Y., Witz, F., et al. (2004). Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: A GOELAMS trial. Blood, 104(10), 3028\u20133037.", "journal-title": "Blood"}, {"key": "12_CR97_12", "author": "RE Parks Jr", "first-page": "483", "year": "1972", "unstructured": "Parks, R. E., Jr., & Agarwal, R. P. (1972). In P. D. Boyer (Ed.), The Enzymes (pp. 483\u2013514). New York: Academic.", "volume-title": "The Enzymes"}, {"issue": "7786", "key": "12_CR98_12", "doi-asserted-by": "publisher", "first-page": "1067", "DOI": "10.1016/S0140-6736(72)92345-8", "volume": "2", "author": "ER Giblett", "year": "1972", "unstructured": "Giblett, E. R., Anderson, J. E., Cohen, F., Pollara, B., & Meuwissen, H. J. (1972). Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet, 2(7786), 1067\u20131069.", "journal-title": "Lancet"}, {"issue": "8", "key": "12_CR99_12", "doi-asserted-by": "publisher", "first-page": "4593", "DOI": "10.1073/pnas.071050798", "volume": "98", "author": "GA Kicska", "year": "2001", "unstructured": "Kicska, G. A., Long, L., Horig, H., Fairchild, C., Tyler, P. C., Furneaux, R. H., et al. (2001). Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4593\u20134598.", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America"}, {"issue": "13", "key": "12_CR100_12", "doi-asserted-by": "publisher", "first-page": "4253", "DOI": "10.1182/blood-2005-03-1309", "volume": "106", "author": "V Gandhi", "year": "2005", "unstructured": "Gandhi, V., Kilpatrick, J. M., Plunkett, W., Ayres, M., Harman, L., Du, M., et al. (2005). A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood, 106(13), 4253\u20134260.", "journal-title": "Blood"}, {"issue": "15", "key": "12_CR101_12", "first-page": "3352", "volume": "55", "author": "CU Lambe", "year": "1995", "unstructured": "Lambe, C. U., Averett, D. R., Paff, M. T., Reardon, J. E., Wilson, J. G., & Krenitsky, T. A. (1995). 2-amino-6-methoxypurine arabinoside: An agent for T-cell malignancies. Cancer Research, 55(15), 3352\u20133356.", "journal-title": "Cancer Research"}, {"issue": "4", "key": "12_CR102_12", "first-page": "660", "volume": "61", "author": "A Cohen", "year": "1983", "unstructured": "Cohen, A., Lee, J. W., & Gelfand, E. W. (1983). Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells. Blood, 61(4), 660\u2013666.", "journal-title": "Blood"}, {"issue": "4", "key": "12_CR103_12", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.1097/00007890-199110000-00011", "volume": "52", "author": "ME Hebert", "year": "1991", "unstructured": "Hebert, M. E., Greenberg, M. L., Chaffee, S., Gravatt, L., Hershfield, M. S., Elion, G. B., et al. (1991). Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanine. Transplantation, 52(4), 634\u2013640.", "journal-title": "Transplantation"}, {"issue": "15", "key": "12_CR104_12", "doi-asserted-by": "publisher", "first-page": "3396", "DOI": "10.1200/JCO.2005.03.199", "volume": "23", "author": "J Kurtzberg", "year": "2005", "unstructured": "Kurtzberg, J., Ernst, T. J., Keating, M. J., Gandhi, V., Hodge, J. P., Kisor, D. F., et al. (2005). Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. Journal of Clinical Oncology, 23(15), 3396\u20133403.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "12", "key": "12_CR105_12", "doi-asserted-by": "publisher", "first-page": "5136", "DOI": "10.1182/blood-2006-11-056754", "volume": "109", "author": "DJ DeAngelo", "year": "2007", "unstructured": "DeAngelo, D. J., Yu, D., Johnson, J. L., Coutre, S. E., Stone, R. M., Stopeck, A. T., et al. (2007). Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and leukemia group B study 19801. Blood, 109(12), 5136\u20135142.", "journal-title": "Blood"}, {"issue": "15", "key": "12_CR106_12", "doi-asserted-by": "publisher", "first-page": "3376", "DOI": "10.1200/JCO.2005.03.426", "volume": "23", "author": "SL Berg", "year": "2005", "unstructured": "Berg, S. L., Blaney, S. M., Devidas, M., Lampkin, T. A., Murgo, A., Bernstein, M., et al. (2005). Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the children\u2019s oncology group. Journal of Clinical Oncology, 23(15), 3376\u20133382.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "18", "key": "12_CR107_12", "doi-asserted-by": "publisher", "first-page": "5329", "DOI": "10.1158/1078-0432.CCR-06-0606", "volume": "12", "author": "MH Cohen", "year": "2006", "unstructured": "Cohen, M. H., Johnson, J. R., Massie, T., Sridhara, R., McGuinn, W. D., Jr., Abraham, S., et al. (2006). Approval summary: Nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma. Clinical Cancer Research, 12(18), 5329\u20135335.", "journal-title": "Clinical Cancer Research"}, {"issue": "10", "key": "12_CR108_12", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1038/nrd2055", "volume": "5", "author": "PL Bonate", "year": "2006", "unstructured": "Bonate, P. L., Arthaud, L., Cantrell, W. R., Jr., Stephenson, K., Secrist, J. A., 3rd, & Weitman, S. (2006). Discovery and development of clofarabine: A nucleoside analogue for treating cancer. Nature Reviews. Drug Discovery, 5(10), 855\u2013863.", "journal-title": "Nature Reviews. Drug Discovery"}, {"issue": "3", "key": "12_CR109_12", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1182/blood-2003-06-2122", "volume": "103", "author": "S Jeha", "year": "2004", "unstructured": "Jeha, S., Gandhi, V., Chan, K. W., McDonald, L., Ramirez, I., Madden, R., et al. (2004). Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood, 103(3), 784\u2013789.", "journal-title": "Blood"}, {"issue": "12", "key": "12_CR110_12", "doi-asserted-by": "publisher", "first-page": "1917", "DOI": "10.1200/JCO.2005.03.8554", "volume": "24", "author": "S Jeha", "year": "2006", "unstructured": "Jeha, S., Gaynon, P. S., Razzouk, B. I., Franklin, J., Kadota, R., Shen, V., et al. (2006). Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of Clinical Oncology, 24(12), 1917\u20131923.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "3\u20134", "key": "12_CR111_12", "first-page": "169", "volume": "79", "author": "J Choi", "year": "2006", "unstructured": "Choi, J., & Foss, F. (2006). Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia. The Yale Journal of Biology and Medicine, 79(3\u20134), 169\u2013172.", "journal-title": "The Yale Journal of Biology and Medicine"}, {"issue": "23", "key": "12_CR112_12", "first-page": "6573", "volume": "60", "author": "M Omura-Minamisawa", "year": "2000", "unstructured": "Omura-Minamisawa, M., Diccianni, M. B., Batova, A., Chang, R. C., Bridgeman, L. J., Yu, J., et al. (2000). In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study. Cancer Research, 60(23), 6573\u20136576.", "journal-title": "Cancer Research"}, {"issue": "7", "key": "12_CR113_12", "doi-asserted-by": "publisher", "first-page": "1569", "DOI": "10.1002/cncr.21776", "volume": "106", "author": "DA Thomas", "year": "2006", "unstructured": "Thomas, D. A., Faderl, S., O\u2019Brien, S., Bueso-Ramos, C., Cortes, J., Garcia-Manero, G., et al. (2006). Chemoimmunotherapy with hyper-CVAD plus Rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 106(7), 1569\u20131580.", "journal-title": "Cancer"}, {"issue": "4", "key": "12_CR114_12", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1007/s00277-003-0752-8", "volume": "83", "author": "N Gokbuget", "year": "2004", "unstructured": "Gokbuget, N., & Hoelzer, D. (2004). Treatment with monoclonal antibodies in acute lymphoblastic leukemia: Current knowledge and future prospects. Annals of Hematology, 83(4), 201\u2013205.", "journal-title": "Annals of Hematology"}, {"issue": "2", "key": "12_CR115_12", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1007/s11060-006-9218-x", "volume": "81", "author": "S Phuphanich", "year": "2007", "unstructured": "Phuphanich, S., Maria, B., Braeckman, R., & Chamberlain, M. (2007). A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. Journal of Neurooncology, 81(2), 201\u2013208.", "journal-title": "Journal of Neurooncology"}], "container-title": ["Adult Acute Lymphocytic Leukemia"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60761-707-5_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T06:29:17Z", "timestamp": 1553236157000}, "score": 33.578262, "issued": {"date-parts": [[2010, 10, 19]]}, "ISBN": ["9781607617068", "9781607617075"], "references-count": 115, "URL": "http://dx.doi.org/10.1007/978-1-60761-707-5_12", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:13:37Z", "timestamp": 1574334817000}, "reference-count": 23, "publisher": "Informa UK Limited", "issue": "sup1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[1993, 1]]}, "DOI": "10.3109/10428199309047892", "type": "journal-article", "created": {"date-parts": [[2007, 11, 30]], "date-time": "2007-11-30T05:05:46Z", "timestamp": 1196399146000}, "page": "235-237", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Differences Between Blastic Chronic Myeloid Leukemia and Ph-Positive Acute Leukemia"], "prefix": "10.1080", "volume": "11", "author": [{"given": "Roland", "family": "Berger", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "CIT0001", "DOI": "10.1111/j.1365-2141.1979.tb01161.x", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1016/0145-2126(90)90155-3", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Bernstein R", "volume": "25", "first-page": "20", "year": "1988", "journal-title": "Sem. Hematol."}, {"key": "CIT0004", "unstructured": "Sandberg A. A. The Chromosomes in Human Cancer and Leukemia, 2nd edn. Elsevier, New York 1990; 427\u2013520"}, {"key": "CIT0005", "DOI": "10.1016/0165-4608(90)90041-8", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "author": "Bernstein R.", "volume": "4", "first-page": "65", "year": "1990", "journal-title": "Leukemia"}, {"key": "CIT0007", "DOI": "10.1016/0145-2126(83)90046-2", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "author": "Russo C.", "volume": "77", "first-page": "1050", "year": "1991", "journal-title": "Blood"}, {"key": "CIT0009", "author": "Secker-Walker L. M.", "volume": "72", "first-page": "784", "year": "1988", "journal-title": "Blood"}, {"key": "CIT0010", "DOI": "10.1016/0165-4608(85)90039-1", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1111/j.1365-2141.1988.tb02426.x", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1111/j.1365-2141.1988.tb02428.x", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "author": "Tachibana N.", "volume": "70", "first-page": "1458", "year": "1987", "journal-title": "Blood"}, {"key": "CIT0014", "DOI": "10.1111/j.1365-2141.1990.tb07834.x", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "author": "Birnie G. D.", "volume": "3", "first-page": "545", "year": "1989", "journal-title": "Leukemia"}, {"key": "CIT0016", "author": "Selleri L.", "volume": "75", "first-page": "1146", "year": "1990", "journal-title": "Blood"}, {"key": "CIT0017", "author": "Dhingra K.", "volume": "5", "first-page": "191", "year": "1991", "journal-title": "Leukemia"}, {"key": "CIT0018", "author": "Soekarman D.", "volume": "4", "first-page": "397", "year": "1990", "journal-title": "Leukemia"}, {"key": "CIT0019", "author": "van der Plas D. C.", "volume": "5", "first-page": "457", "year": "1991", "journal-title": "Leukemia"}, {"key": "CIT0020", "author": "Kantarjian H. M.", "volume": "78", "first-page": "2411", "year": "1991", "journal-title": "Blood"}, {"key": "CIT0021", "author": "Soussi T.", "volume": "33", "first-page": "477", "year": "1991", "journal-title": "Nouv. Rev. Fr. H\u00e9matol."}, {"issue": "1", "key": "CIT0022", "first-page": "37", "volume": "6", "author": "Feinstein E.", "year": "1992", "journal-title": "Leukemia"}, {"key": "CIT0023", "DOI": "10.1016/0165-4608(91)90207-B", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10428199309047892", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T18:25:43Z", "timestamp": 1481826343000}, "score": 33.230103, "issued": {"date-parts": [[1993, 1]]}, "references-count": 23, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[1993, 1]]}, "issue": "sup1"}, "alternative-id": ["10.3109/10428199309047892"], "URL": "http://dx.doi.org/10.3109/10428199309047892", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:24:35Z", "timestamp": 1574479475988}, "publisher-location": "Totowa, NJ", "reference-count": 139, "publisher": "Humana Press", "isbn-type": [{"value": "9781607617068", "type": "print"}, {"value": "9781607617075", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-1-60761-707-5_10", "type": "book-chapter", "created": {"date-parts": [[2010, 11, 17]], "date-time": "2010-11-17T18:44:45Z", "timestamp": 1290019485000}, "page": "127-144", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pharmacology of Acute Lymphoblastic Leukemia Therapy"], "prefix": "10.1007", "author": [{"given": "Paul M.", "family": "Barr", "sequence": "first", "affiliation": []}, {"given": "Richard J.", "family": "Creger", "sequence": "additional", "affiliation": []}, {"given": "Nathan A.", "family": "Berger", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 10, 19]]}, "reference": [{"issue": "787", "key": "10_CR1_10", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1056/NEJM194806032382301", "volume": "238", "author": "S Farber", "year": "1948", "unstructured": "Farber, S., et al. (1948). Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroylglutamic acid (aminopterin). The New England Journal of Medicine, 238(787), 787\u2013793.", "journal-title": "The New England Journal of Medicine"}, {"issue": "12 Pt 1", "key": "10_CR2_10", "first-page": "6523", "volume": "45", "author": "E Frei 3rd", "year": "1985", "unstructured": "Frei, E., 3rd. (1985). Curative cancer chemotherapy. Cancer Research, 45(12 Pt 1), 6523\u20136537.", "journal-title": "Cancer Research"}, {"issue": "11 Suppl", "key": "10_CR3_10", "doi-asserted-by": "publisher", "first-page": "2599", "DOI": "10.1002/1097-0142(19841201)54:2+<2599::AID-CNCR2820541403>3.0.CO;2-M", "volume": "54", "author": "BA Chabner", "year": "1984", "unstructured": "Chabner, B. A., et al. (1984). Cancer chemotherapy. Progress and expectations. Cancer, 54(11 Suppl), 2599\u20132608.", "journal-title": "Cancer"}, {"key": "10_CR4_10", "first-page": "20", "volume": "5", "author": "E Freireich", "year": "1964", "unstructured": "Freireich, E., Karon, M., & Frei, I. E. (1964). Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood. Proceedings of the American Association for Cancer Research, 5, 20.", "journal-title": "Proceedings of the American Association for Cancer Research"}, {"issue": "4", "key": "10_CR5_10", "doi-asserted-by": "publisher", "first-page": "1679", "DOI": "10.1002/1097-0142(197604)37:4<1679::AID-CNCR2820370411>3.0.CO;2-8", "volume": "37", "author": "G Rivera", "year": "1976", "unstructured": "Rivera, G., et al. (1976). Recurrent childhood lymphocytic leukemia following cessation of therapy: Treatment and response. Cancer, 37(4), 1679\u20131686.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR6_10", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1002/1097-0142(197008)26:2<404::AID-CNCR2820260222>3.0.CO;2-I", "volume": "26", "author": "AE Evans", "year": "1970", "unstructured": "Evans, A. E., Gilbert, E. S., & Zandstra, R. (1970). The increasing incidence of central nervous system leukemia in children. (Children\u2019s Cancer Study Group A). Cancer, 26(2), 404\u2013409.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR7_10", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1200/JCO.1983.1.2.75", "volume": "1", "author": "JF Holland", "year": "1983", "unstructured": "Holland, J. F. (1983). Karnofsky Memorial Lecture. Breaking the cure barrier. Journal of Clinical Oncology, 1(2), 75\u201390.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "2", "key": "10_CR8_10", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1002/1097-0142(197202)29:2<381::AID-CNCR2820290219>3.0.CO;2-P", "volume": "29", "author": "RJ Aur", "year": "1972", "unstructured": "Aur, R. J., et al. (1972). A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer, 29(2), 381\u2013391.", "journal-title": "Cancer"}, {"key": "10_CR9_10", "doi-asserted-by": "publisher", "first-page": "593", "DOI": "10.1007/978-1-4615-4811-9_66", "volume": "457", "author": "PS Gaynon", "year": "1999", "unstructured": "Gaynon, P. S., & Carrel, A. L. (1999). Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Advances in Experimental Medicine and Biology, 457, 593\u2013605.", "journal-title": "Advances in Experimental Medicine and Biology"}, {"issue": "1", "key": "10_CR10_10", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1038/sj.cdd.4400969", "volume": "9", "author": "CW Distelhorst", "year": "2002", "unstructured": "Distelhorst, C. W. (2002). Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death and Differentiation, 9(1), 6\u201319.", "journal-title": "Cell Death and Differentiation"}, {"issue": "2", "key": "10_CR11_10", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/S0022-3476(78)80529-0", "volume": "93", "author": "OC Green", "year": "1978", "unstructured": "Green, O. C., et al. (1978). Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. Journal de Pediatria, 93(2), 299\u2013303.", "journal-title": "Journal de Pediatria"}, {"issue": "4", "key": "10_CR12_10", "doi-asserted-by": "publisher", "first-page": "390", "DOI": "10.1038/clpt.1990.167", "volume": "48", "author": "MR Hill", "year": "1990", "unstructured": "Hill, M. R., et al. (1990). Monitoring glucocorticoid therapy: A pharmacokinetic approach. Clinical Pharmacology and Therapeutics, 48(4), 390\u2013398.", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"issue": "3\u20134", "key": "10_CR13_10", "first-page": "329", "volume": "3", "author": "O Richter", "year": "1983", "unstructured": "Richter, O., et al. (1983). Pharmacokinetics of dexamethasone in children. Pediatric Pharmacology (New York), 3(3\u20134), 329\u2013337.", "journal-title": "Pediatric Pharmacology (New York)"}, {"issue": "12", "key": "10_CR14_10", "doi-asserted-by": "publisher", "first-page": "1932", "DOI": "10.1200/JCO.2007.13.8404", "volume": "26", "author": "L Yang", "year": "2008", "unstructured": "Yang, L., et al. (2008). Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. Journal of Clinical Oncology, 26(12), 1932\u20131939.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "3", "key": "10_CR15_10", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1002/1097-0142(196803)21:3<346::AID-CNCR2820210303>3.0.CO;2-Y", "volume": "21", "author": "SL Leikin", "year": "1968", "unstructured": "Leikin, S. L., et al. (1968). Varying prednisone dosage in remission induction of previously untreated childhood leukemia. Cancer, 21(3), 346\u2013351.", "journal-title": "Cancer"}, {"issue": "5", "key": "10_CR16_10", "first-page": "301", "volume": "64", "author": "B Bannwarth", "year": "1997", "unstructured": "Bannwarth, B., et al. (1997). Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data. Revue du Rhumatisme. English Edition, 64(5), 301\u2013304.", "journal-title": "Revue du Rhumatisme. English Edition"}, {"issue": "2", "key": "10_CR17_10", "doi-asserted-by": "crossref", "first-page": "202", "DOI": "10.1200/JCO.1987.5.2.202", "volume": "5", "author": "FM Balis", "year": "1987", "unstructured": "Balis, F. M., et al. (1987). Differences in cerebrospinal fluid penetration of corticosteroids: Possible relationship to the prevention of meningeal leukemia. Journal of Clinical Oncology, 5(2), 202\u2013207.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "10", "key": "10_CR18_10", "doi-asserted-by": "publisher", "first-page": "3809", "DOI": "10.1182/blood-2002-08-2454", "volume": "101", "author": "BC Bostrom", "year": "2003", "unstructured": "Bostrom, B. C., et al. (2003). Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children\u2019s Cancer Group. Blood, 101(10), 3809\u20133817.", "journal-title": "Blood"}, {"issue": "5", "key": "10_CR19_10", "doi-asserted-by": "crossref", "first-page": "1277", "DOI": "10.1016/S0025-7125(16)32228-3", "volume": "57", "author": "DC Dale", "year": "1973", "unstructured": "Dale, D. C., & Petersdorf, R. G. (1973). Corticosteroids and infectious diseases. The Medical Clinics of North America, 57(5), 1277\u20131287.", "journal-title": "The Medical Clinics of North America"}, {"issue": "6", "key": "10_CR20_10", "doi-asserted-by": "publisher", "first-page": "970", "DOI": "10.1111/1523-1747.ep12384210", "volume": "102", "author": "FK Jugert", "year": "1994", "unstructured": "Jugert, F. K., et al. (1994). Multiple cytochrome P450 isozymes in murine skin: Induction of P450 1A, 2B, 2E, and 3A by dexamethasone. Journal of Investigative Dermatology, 102(6), 970\u2013975.", "journal-title": "Journal of Investigative Dermatology"}, {"key": "10_CR21_10", "first-page": "91", "volume-title": "Cancer chemotherapy and biotherapy", "author": "B Chabner", "year": "2006", "unstructured": "Chabner, B., & Longo, D. L. (2006). Cancer chemotherapy and biotherapy (4th ed., pp. 91\u2013124). Philadelphia: Lippincott Williams & Wilkins.", "edition": "4"}, {"issue": "5", "key": "10_CR22_10", "first-page": "2342", "volume": "43", "author": "FM Balis", "year": "1983", "unstructured": "Balis, F. M., Savitch, J. L., & Bleyer, W. A. (1983). Pharmacokinetics of oral methotrexate in children. Cancer Research, 43(5), 2342\u20132345.", "journal-title": "Cancer Research"}, {"issue": "4", "key": "10_CR23_10", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1007/BF00254738", "volume": "3", "author": "JF Stuart", "year": "1979", "unstructured": "Stuart, J. F., et al. (1979). Bioavailability of methotrexate: Implications for clinical use. Cancer Chemotherapy and Pharmacology, 3(4), 239\u2013241.", "journal-title": "Cancer Chemotherapy and Pharmacology"}, {"issue": "15", "key": "10_CR24_10", "doi-asserted-by": "publisher", "first-page": "4757", "DOI": "10.1021/bi00389a024", "volume": "26", "author": "EM Price", "year": "1987", "unstructured": "Price, E. M., & Freisheim, J. H. (1987). Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells. Biochemistry, 26(15), 4757\u20134763.", "journal-title": "Biochemistry"}, {"issue": "28", "key": "10_CR25_10", "first-page": "13520", "volume": "262", "author": "CJ Allegra", "year": "1987", "unstructured": "Allegra, C. J., et al. (1987). Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. The Journal of Biological Chemistry, 262(28), 13520\u201313526.", "journal-title": "The Journal of Biological Chemistry"}, {"issue": "12", "key": "10_CR26_10", "doi-asserted-by": "publisher", "first-page": "630", "DOI": "10.1056/NEJM197709222971203", "volume": "297", "author": "RG Stoller", "year": "1977", "unstructured": "Stoller, R. G., et al. (1977). Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. The New England Journal of Medicine, 297(12), 630\u2013634.", "journal-title": "The New England Journal of Medicine"}, {"issue": "8", "key": "10_CR27_10", "doi-asserted-by": "publisher", "first-page": "471", "DOI": "10.1056/NEJM198602203140803", "volume": "314", "author": "WE Evans", "year": "1986", "unstructured": "Evans, W. E., et al. (1986). Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. The New England Journal of Medicine, 314(8), 471\u2013477.", "journal-title": "The New England Journal of Medicine"}, {"issue": "4", "key": "10_CR28_10", "first-page": "745", "volume": "61", "author": "DD Hoff Von", "year": "1977", "unstructured": "Von Hoff, D. D., et al. (1977). Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. Cancer Treatment Reports, 61(4), 745\u2013748.", "journal-title": "Cancer Treatment Reports"}, {"issue": "12", "key": "10_CR29_10", "doi-asserted-by": "crossref", "first-page": "2017", "DOI": "10.1200/JCO.1987.5.12.2017", "volume": "5", "author": "SP Ackland", "year": "1987", "unstructured": "Ackland, S. P., & Schilsky, R. L. (1987). High-dose methotrexate: A critical reappraisal. Journal of Clinical Oncology, 5(12), 2017\u20132031.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "5", "key": "10_CR30_10", "doi-asserted-by": "publisher", "first-page": "702", "DOI": "10.2165/00003495-199141050-00003", "volume": "41", "author": "SM Blaney", "year": "1991", "unstructured": "Blaney, S. M., Balis, F. M., & Poplack, D. G. (1991). Current pharmacological treatment approaches to central nervous system leukaemia. Drugs, 41(5), 702\u2013716.", "journal-title": "Drugs"}, {"issue": "6", "key": "10_CR31_10", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1016/S0272-6386(96)90384-4", "volume": "28", "author": "MW Susan", "year": "1996", "unstructured": "Susan, M. W., et al. (1996). Effective clearance of methotrexate using high-flux hemodialysis membranes. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 28(6), 846\u2013854.", "journal-title": "American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation"}, {"issue": "5", "key": "10_CR32_10", "doi-asserted-by": "crossref", "first-page": "2125", "DOI": "10.1200/JCO.1997.15.5.2125", "volume": "15", "author": "BC Widemann", "year": "1997", "unstructured": "Widemann, B. C., et al. (1997). Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. Journal of Clinical Oncology, 15(5), 2125\u20132134.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "3", "key": "10_CR33_10", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1038/sj.bjc.6602337", "volume": "92", "author": "S Buchen", "year": "2005", "unstructured": "Buchen, S., et al. (2005). Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. British Journal of Cancer, 92(3), 480\u2013487.", "journal-title": "British Journal of Cancer"}, {"issue": "4", "key": "10_CR34_10", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1097/00043426-200205000-00021", "volume": "24", "author": "JH Dalle", "year": "2002", "unstructured": "Dalle, J. H., et al. (2002). Interaction between methotrexate and ciprofloxacin. Journal of Pediatric Hematology/Oncology, 24(4), 321\u2013322.", "journal-title": "Journal of Pediatric Hematology/Oncology"}, {"issue": "4", "key": "10_CR35_10", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1007/BF00264201", "volume": "21", "author": "H Iven", "year": "1988", "unstructured": "Iven, H., & Brasch, H. (1988). The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits. Cancer Chemotherapy and Pharmacology, 21(4), 337\u2013342.", "journal-title": "Cancer Chemotherapy and Pharmacology"}, {"issue": "2", "key": "10_CR36_10", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1007/BF02897260", "volume": "26", "author": "H Iven", "year": "1990", "unstructured": "Iven, H., & Brasch, H. (1990). Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits. Cancer Chemotherapy and Pharmacology, 26(2), 139\u2013143.", "journal-title": "Cancer Chemotherapy and Pharmacology"}, {"issue": "8475", "key": "10_CR37_10", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1016/S0140-6736(86)90786-5", "volume": "1", "author": "A Thyss", "year": "1986", "unstructured": "Thyss, A., et al. (1986). Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet, 1(8475), 256\u2013258.", "journal-title": "Lancet"}, {"key": "10_CR38_10", "first-page": "212", "volume-title": "Cancer chemotherapy and biotherapy", "author": "B Chabner", "year": "2006", "unstructured": "Chabner, B., & Longo, D. L. (2006). Cancer chemotherapy and biotherapy (4th ed., pp. 212\u2013228). Philadelphia: Lippincott Williams & Wilkins.", "edition": "4"}, {"issue": "4", "key": "10_CR39_10", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1038/clpt.1987.45", "volume": "41", "author": "FM Balis", "year": "1987", "unstructured": "Balis, F. M., et al. (1987). The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clinical Pharmacology and Therapeutics, 41(4), 384\u2013387.", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"issue": "11", "key": "10_CR40_10", "first-page": "1627", "volume": "31", "author": "GA LePage", "year": "1971", "unstructured": "LePage, G. A., & Whitecar, J. P., Jr. (1971). Pharmacology of 6-thioguanine in man. Cancer Research, 31(11), 1627\u20131631.", "journal-title": "Cancer Research"}, {"issue": "1", "key": "10_CR41_10", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1056/NEJM199007053230104", "volume": "323", "author": "G Koren", "year": "1990", "unstructured": "Koren, G., et al. (1990). Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. The New England Journal of Medicine, 323(1), 17\u201321.", "journal-title": "The New England Journal of Medicine"}, {"issue": "12", "key": "10_CR42_10", "doi-asserted-by": "crossref", "first-page": "1816", "DOI": "10.1200/JCO.1989.7.12.1816", "volume": "7", "author": "L Lennard", "year": "1989", "unstructured": "Lennard, L., & Lilleyman, J. S. (1989). Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. Journal of Clinical Oncology, 7(12), 1816\u20131823.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "4", "key": "10_CR43_10", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1002/j.1552-4604.1990.tb03606.x", "volume": "30", "author": "GL Chan", "year": "1990", "unstructured": "Chan, G. L., et al. (1990). Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. Journal of Clinical Pharmacology, 30(4), 358\u2013363.", "journal-title": "Journal of Clinical Pharmacology"}, {"issue": "2", "key": "10_CR44_10", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1038/clpt.1989.119", "volume": "46", "author": "L Lennard", "year": "1989", "unstructured": "Lennard, L., Van Loon, J. A., & Weinshilboum, R. M. (1989). Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism. Clinical Pharmacology and Therapeutics, 46(2), 149\u2013154.", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"issue": "8709", "key": "10_CR45_10", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1016/0140-6736(90)91745-V", "volume": "336", "author": "L Lennard", "year": "1990", "unstructured": "Lennard, L., et al. (1990). Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet, 336(8709), 225\u2013229.", "journal-title": "Lancet"}, {"issue": "6", "key": "10_CR46_10", "doi-asserted-by": "publisher", "first-page": "810", "DOI": "10.1038/clpt.1983.254", "volume": "34", "author": "S Zimm", "year": "1983", "unstructured": "Zimm, S., et al. (1983). Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol. Clinical Pharmacology and Therapeutics, 34(6), 810\u2013817.", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"issue": "2", "key": "10_CR47_10", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/0002-9343(92)90116-S", "volume": "92", "author": "JD Singleton", "year": "1992", "unstructured": "Singleton, J. D., & Conyers, L. (1992). Warfarin and azathioprine: An important drug interaction. The American Journal of Medicine, 92(2), 217.", "journal-title": "The American Journal of Medicine"}, {"issue": "3", "key": "10_CR48_10", "doi-asserted-by": "publisher", "first-page": "816", "DOI": "10.1021/jo01278a069", "volume": "32", "author": "WK Roberts", "year": "1967", "unstructured": "Roberts, W. K., & Dekker, C. A. (1967). A convenient synthesis of arabinosylcytosine (cytosine arabinoside). The Journal of Organic Chemistry, 32(3), 816\u2013817.", "journal-title": "The Journal of Organic Chemistry"}, {"issue": "3", "key": "10_CR49_10", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1002/1097-0142(196803)21:3<341::AID-CNCR2820210302>3.0.CO;2-F", "volume": "21", "author": "JP Howard", "year": "1968", "unstructured": "Howard, J. P., Albo, V., & Newton, W. A., Jr. (1968). Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia. Cancer, 21(3), 341\u2013345.", "journal-title": "Cancer"}, {"issue": "4", "key": "10_CR50_10", "first-page": "507", "volume": "32", "author": "RR Ellison", "year": "1968", "unstructured": "Ellison, R. R., et al. (1968). Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood, 32(4), 507\u2013523.", "journal-title": "Blood"}, {"issue": "19", "key": "10_CR51_10", "first-page": "8997", "volume": "255", "author": "DW Kufe", "year": "1980", "unstructured": "Kufe, D. W., et al. (1980). Correlation of cytotoxicity with incorporation of ara-C into DNA. The Journal of Biological Chemistry, 255(19), 8997\u20139000.", "journal-title": "The Journal of Biological Chemistry"}, {"issue": "5", "key": "10_CR52_10", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1016/0145-2126(90)90035-8", "volume": "14", "author": "GP Jamieson", "year": "1990", "unstructured": "Jamieson, G. P., Snook, M. B., & Wiley, J. S. (1990). Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells. Leukemia Research, 14(5), 475\u2013479.", "journal-title": "Leukemia Research"}, {"issue": "2", "key": "10_CR53_10", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1172/JCI110472", "volume": "69", "author": "JS Wiley", "year": "1982", "unstructured": "Wiley, J. S., et al. (1982). Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. Journal of Clinical Investigation, 69(2), 479\u2013489.", "journal-title": "Journal of Clinical Investigation"}, {"issue": "9", "key": "10_CR54_10", "doi-asserted-by": "crossref", "first-page": "546", "DOI": "10.1200/JCO.1983.1.9.546", "volume": "1", "author": "ML Slevin", "year": "1983", "unstructured": "Slevin, M. L., et al. (1983). Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. Journal of Clinical Oncology, 1(9), 546\u2013551.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "7", "key": "10_CR55_10", "doi-asserted-by": "publisher", "first-page": "1248", "DOI": "10.1002/1097-0142(19821001)50:7<1248::AID-CNCR2820500705>3.0.CO;2-5", "volume": "50", "author": "H Breithaupt", "year": "1982", "unstructured": "Breithaupt, H., et al. (1982). Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C). Cancer, 50(7), 1248\u20131257.", "journal-title": "Cancer"}, {"issue": "6", "key": "10_CR56_10", "doi-asserted-by": "crossref", "first-page": "944", "DOI": "10.1002/cpt1971126944", "volume": "12", "author": "DH Ho", "year": "1971", "unstructured": "Ho, D. H., & Frei, E., III. (1971). Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. Clinical Pharmacology and Therapeutics, 12(6), 944\u2013954.", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"issue": "9", "key": "10_CR57_10", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1001/archneur.1995.00540330094020", "volume": "52", "author": "MC Chamberlain", "year": "1995", "unstructured": "Chamberlain, M. C., et al. (1995). Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Archives of Neurology, 52(9), 912\u2013917.", "journal-title": "Archives of Neurology"}, {"issue": "11", "key": "10_CR58_10", "doi-asserted-by": "crossref", "first-page": "2186", "DOI": "10.1200/JCO.1993.11.11.2186", "volume": "11", "author": "S Kim", "year": "1993", "unstructured": "Kim, S., et al. (1993). Extended CSF cytarabine exposure following intrathecal administration of DTC 101. Journal of Clinical Oncology, 11(11), 2186\u20132193.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "5", "key": "10_CR59_10", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1002/1097-0142(19900301)65:5<1079::AID-CNCR2820650506>3.0.CO;2-K", "volume": "65", "author": "BS Andersson", "year": "1990", "unstructured": "Andersson, B. S., et al. (1990). Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer, 65(5), 1079\u20131084.", "journal-title": "Cancer"}, {"issue": "11", "key": "10_CR60_10", "doi-asserted-by": "publisher", "first-page": "2360", "DOI": "10.1002/1097-0142(19841201)54:11<2360::AID-CNCR2820541109>3.0.CO;2-D", "volume": "54", "author": "CB George", "year": "1984", "unstructured": "George, C. B., et al. (1984). Hepatic dysfunction and jaundice following high-dose cytosine arabinoside. Cancer, 54(11), 2360\u20132362.", "journal-title": "Cancer"}, {"issue": "4 Pt 1", "key": "10_CR61_10", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1016/S0190-9622(84)70210-6", "volume": "11", "author": "TC Flynn", "year": "1984", "unstructured": "Flynn, T. C., et al. (1984). Neutrophilic eccrine hidradenitis: A distinctive rash associated with cytarabine therapy and acute leukemia. Journal of the American Academy of Dermatology, 11(4 Pt 1), 584\u2013590.", "journal-title": "Journal of the American Academy of Dermatology"}, {"issue": "6", "key": "10_CR62_10", "doi-asserted-by": "crossref", "first-page": "948", "DOI": "10.1200/JCO.1992.10.6.948", "volume": "10", "author": "EH Rubin", "year": "1992", "unstructured": "Rubin, E. H., et al. (1992). Risk factors for high-dose cytarabine neurotoxicity: An analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia. Journal of Clinical Oncology, 10(6), 948\u2013953.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "10", "key": "10_CR63_10", "doi-asserted-by": "publisher", "first-page": "2504", "DOI": "10.1002/1097-0142(19921115)70:10<2504::AID-CNCR2820701019>3.0.CO;2-H", "volume": "70", "author": "BK Kleinschmidt-DeMasters", "year": "1992", "unstructured": "Kleinschmidt-DeMasters, B. K., & Yeh, M. (1992). \u201cLocked-in syndrome\u201d after intrathecal cytosine arabinoside therapy for malignant immunoblastic lymphoma. Cancer, 70(10), 2504\u20132507.", "journal-title": "Cancer"}, {"issue": "9", "key": "10_CR64_10", "first-page": "1539", "volume": "3", "author": "V Gandhi", "year": "1997", "unstructured": "Gandhi, V., et al. (1997). Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. Clinical Cancer Research, 3(9), 1539\u20131545.", "journal-title": "Clinical Cancer Research"}, {"issue": "3", "key": "10_CR65_10", "doi-asserted-by": "publisher", "first-page": "788", "DOI": "10.1172/JCI109525", "volume": "64", "author": "E Cadman", "year": "1979", "unstructured": "Cadman, E., & Eiferman, F. (1979). Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: Study of L1210 and human leukemic cells. Journal of Clinical Investigation, 64(3), 788\u2013797.", "journal-title": "Journal of Clinical Investigation"}, {"issue": "2", "key": "10_CR66_10", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1007/s002800100289", "volume": "48", "author": "CH Fu", "year": "2001", "unstructured": "Fu, C. H., et al. (2001). Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein. Cancer Chemotherapy and Pharmacology, 48(2), 123\u2013133.", "journal-title": "Cancer Chemotherapy and Pharmacology"}, {"issue": "2A", "key": "10_CR67_10", "first-page": "727", "volume": "18", "author": "P Nandy", "year": "1998", "unstructured": "Nandy, P., Periclou, A. P., & Avramis, V. I. (1998). The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis. Anticancer Research, 18(2A), 727\u2013737.", "journal-title": "Anticancer Research"}, {"key": "10_CR68_10", "first-page": "31", "volume": "38", "author": "A Dimarco", "year": "1964", "unstructured": "Dimarco, A., et al. (1964). Daunomycin: A new antibiotic with antitumor activity. Cancer Chemotherapy Reports, 38, 31\u201338.", "journal-title": "Cancer Chemotherapy Reports"}, {"issue": "4", "key": "10_CR69_10", "doi-asserted-by": "publisher", "first-page": "780", "DOI": "10.1046/j.1365-2141.2000.t01-1-02153.x", "volume": "110", "author": "EJ Estlin", "year": "2000", "unstructured": "Estlin, E. J., et al. (2000). The clinical and cellular pharmacology of vincristine, corticosteroids, l-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia. British Journal Haematology, 110(4), 780\u2013790.", "journal-title": "British Journal Haematology"}, {"issue": "1", "key": "10_CR70_10", "first-page": "218", "volume": "46", "author": "BA Johnson", "year": "1986", "unstructured": "Johnson, B. A., Cheang, M. S., & Goldenberg, G. J. (1986). Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: Role of drug uptake in cardiotoxicity. Cancer Research, 46(1), 218\u2013223.", "journal-title": "Cancer Research"}, {"issue": "5", "key": "10_CR71_10", "first-page": "637", "volume": "39", "author": "DH Huffman", "year": "1972", "unstructured": "Huffman, D. H., & Bachur, N. R. (1972). Daunorubicin metabolism in acute myelocytic leukemia. Blood, 39(5), 637\u2013643.", "journal-title": "Blood"}, {"issue": "1", "key": "10_CR72_10", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1172/JCI109642", "volume": "65", "author": "JH Doroshow", "year": "1980", "unstructured": "Doroshow, J. H., Locker, G. Y., & Myers, C. E. (1980). Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. Journal of Clinical Investigation, 65(1), 128\u2013135.", "journal-title": "Journal of Clinical Investigation"}, {"issue": "4", "key": "10_CR73_10", "doi-asserted-by": "crossref", "first-page": "1318", "DOI": "10.1200/JCO.1997.15.4.1318", "volume": "15", "author": "SM Swain", "year": "1997", "unstructured": "Swain, S. M., et al. (1997). Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. Journal of Clinical Oncology, 15(4), 1318\u20131332.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "12", "key": "10_CR74_10", "doi-asserted-by": "publisher", "first-page": "745", "DOI": "10.1056/NEJM198809223191203", "volume": "319", "author": "JL Speyer", "year": "1988", "unstructured": "Speyer, J. L., et al. (1988). Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. The New England Journal of Medicine, 319(12), 745\u2013752.", "journal-title": "The New England Journal of Medicine"}, {"issue": "2", "key": "10_CR75_10", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.7326/0003-4819-96-2-133", "volume": "96", "author": "SS Legha", "year": "1982", "unstructured": "Legha, S. S., et al. (1982). Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Annals of Internal Medicine, 96(2), 133\u2013139.", "journal-title": "Annals of Internal Medicine"}, {"issue": "12", "key": "10_CR76_10", "doi-asserted-by": "publisher", "first-page": "808", "DOI": "10.1056/NEJM199103213241205", "volume": "324", "author": "SE Lipshultz", "year": "1991", "unstructured": "Lipshultz, S. E., et al. (1991). Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. The New England Journal of Medicine, 324(12), 808\u2013815.", "journal-title": "The New England Journal of Medicine"}, {"issue": "6", "key": "10_CR77_10", "doi-asserted-by": "publisher", "first-page": "278", "DOI": "10.1056/NEJM197902083000603", "volume": "300", "author": "J Alexander", "year": "1979", "unstructured": "Alexander, J., et al. (1979). Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. The New England Journal of Medicine, 300(6), 278\u2013283.", "journal-title": "The New England Journal of Medicine"}, {"issue": "2", "key": "10_CR78_10", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1016/0002-9343(77)90315-1", "volume": "62", "author": "DD Hoff Von", "year": "1977", "unstructured": "Von Hoff, D. D., et al. (1977). Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. The American Journal of Medicine, 62(2), 200\u2013208.", "journal-title": "The American Journal of Medicine"}, {"key": "10_CR79_10", "first-page": "237", "volume-title": "Cancer chemotherapy and biotherapy: Principles and practice", "author": "EK Rowinsky", "year": "2006", "unstructured": "Rowinsky, E. K. (2006). Antimicrotubule Agents. In B. A. Chabner & D. L. Longo (Eds.), Cancer chemotherapy and biotherapy: Principles and practice (4th ed., pp. 237\u2013282). Philadelphia: Lippincott Williams & Wilkins.", "edition": "4"}, {"issue": "3", "key": "10_CR80_10", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1007/s002800050968", "volume": "44", "author": "CE Gidding", "year": "1999", "unstructured": "Gidding, C. E., et al. (1999). Vincristine pharmacokinetics after repetitive dosing in children. Cancer Chemotherapy and Pharmacology, 44(3), 203\u2013209.", "journal-title": "Cancer Chemotherapy and Pharmacology"}, {"issue": "3", "key": "10_CR81_10", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1016/S1040-8428(98)00023-7", "volume": "29", "author": "CE Gidding", "year": "1999", "unstructured": "Gidding, C. E., et al. (1999). Vincristine revisited. Critical Reviews in Oncology/Hematology, 29(3), 267\u2013287.", "journal-title": "Critical Reviews in Oncology/Hematology"}, {"issue": "11\u201312", "key": "10_CR82_10", "first-page": "1043", "volume": "65", "author": "DV Jackson Jr", "year": "1981", "unstructured": "Jackson, D. V., Jr., et al. (1981). Pharmacokinetics of vincristine infusion. Cancer Treatment Reports, 65(11\u201312), 1043\u20131048.", "journal-title": "Cancer Treatment Reports"}, {"issue": "1", "key": "10_CR83_10", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1007/PL00007853", "volume": "249", "author": "S Quasthoff", "year": "2002", "unstructured": "Quasthoff, S., & Hartung, H. P. (2002). Chemotherapy-induced peripheral neuropathy. Journal of Neurology, 249(1), 9\u201317.", "journal-title": "Journal of Neurology"}, {"issue": "5", "key": "10_CR84_10", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1097/00019052-200210000-00015", "volume": "15", "author": "AC Peltier", "year": "2002", "unstructured": "Peltier, A. C., & Russell, J. W. (2002). Recent advances in drug-induced neuropathies. Current Opinion in Neurology, 15(5), 633\u2013638.", "journal-title": "Current Opinion in Neurology"}, {"issue": "4", "key": "10_CR85_10", "first-page": "915", "volume": "33", "author": "M Colvin", "year": "1973", "unstructured": "Colvin, M., Padgett, C. A., & Fenselau, C. (1973). A biologically active metabolite of cyclophosphamide. Cancer Research, 33(4), 915\u2013918.", "journal-title": "Cancer Research"}, {"issue": "4", "key": "10_CR86_10", "first-page": "803", "volume": "55", "author": "SM Yule", "year": "1995", "unstructured": "Yule, S. M., et al. (1995). Cyclophosphamide metabolism in children. Cancer Research, 55(4), 803\u2013809.", "journal-title": "Cancer Research"}, {"issue": "10", "key": "10_CR87_10", "first-page": "2723", "volume": "47", "author": "RF Struck", "year": "1987", "unstructured": "Struck, R. F., et al. (1987). Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial. Cancer Research, 47(10), 2723\u20132726.", "journal-title": "Cancer Research"}, {"issue": "1", "key": "10_CR88_10", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1111/j.1365-2125.1996.tb00153.x", "volume": "41", "author": "SM Yule", "year": "1996", "unstructured": "Yule, S. M., et al. (1996). Cyclophosphamide pharmacokinetics in children. British Journal of Clinical Pharmacology, 41(1), 13\u201319.", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10_CR89_10", "first-page": "283", "volume-title": "Cancer chemotherapy and biotherapy: Principles and practice", "author": "KD Tew", "year": "2006", "unstructured": "Tew, K. D., Colvin, O. M., & Jones, R. B. (2006). Clinical and high-dose alkylating agents. In B. A. Chabner & D. L. Longo (Eds.), Cancer chemotherapy and biotherapy: Principles and practice (4th ed., pp. 283\u2013309). Philadelphia: Lippincott Williams & Wilkins.", "edition": "4"}, {"issue": "12", "key": "10_CR90_10", "doi-asserted-by": "crossref", "first-page": "1732", "DOI": "10.1200/JCO.1986.4.12.1732", "volume": "4", "author": "SB Murphy", "year": "1986", "unstructured": "Murphy, S. B., et al. (1986). Results of treatment of advanced-stage Burkitt\u2019s lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. Journal of Clinical Oncology, 4(12), 1732\u20131739.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "Suppl 5", "key": "10_CR91_10", "first-page": "409", "volume": "36", "author": "HT Mouridsen", "year": "1975", "unstructured": "Mouridsen, H. T., & Jacobsen, E. (1975). Pharmacokinetics of cyclophosphamide in renal failure. Acta Pharmacologica et Toxicologica, 36(Suppl 5), 409\u2013414.", "journal-title": "Acta Pharmacologica et Toxicologica"}, {"issue": "12", "key": "10_CR92_10", "doi-asserted-by": "publisher", "first-page": "1662", "DOI": "10.1001/jama.217.12.1662", "volume": "217", "author": "DG Miller", "year": "1971", "unstructured": "Miller, D. G. (1971). Alkylating agents and human spermatogenesis. Journal of the American Medical Association, 217(12), 1662\u20131665.", "journal-title": "Journal of the American Medical Association"}, {"issue": "7762", "key": "10_CR93_10", "doi-asserted-by": "publisher", "first-page": "1212", "DOI": "10.1016/S0140-6736(72)90927-0", "volume": "1", "author": "R Kumar", "year": "1972", "unstructured": "Kumar, R., et al. (1972). Cyclophosphamide and reproductive function. Lancet, 1(7762), 1212\u20131214.", "journal-title": "Lancet"}, {"issue": "4", "key": "10_CR94_10", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1016/0002-9343(71)90341-X", "volume": "50", "author": "J. J. Miller", "year": "3rd", "unstructured": "Miller, J. J., 3rd, Williams, G. F., and Leissring, J. C. (1971). Multiple late complications of therapy with cyclophosphamide, including ovarian destruction. The American Journal of Medicine, 50(4), 530\u2013535.", "journal-title": "The American Journal of Medicine"}, {"issue": "2", "key": "10_CR95_10", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1056/NEJM198801143180203", "volume": "318", "author": "MA Tucker", "year": "1988", "unstructured": "Tucker, M. A., et al. (1988). Risk of second cancers after treatment for Hodgkin\u2019s disease. The New England Journal of Medicine, 318(2), 76\u201381.", "journal-title": "The New England Journal of Medicine"}, {"issue": "5", "key": "10_CR96_10", "first-page": "1114", "volume": "68", "author": "MA Goldberg", "year": "1986", "unstructured": "Goldberg, M. A., et al. (1986). Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood, 68(5), 1114\u20131118.", "journal-title": "Blood"}, {"issue": "12", "key": "10_CR97_10", "first-page": "2761", "volume": "32", "author": "JY Jao", "year": "1972", "unstructured": "Jao, J. Y., Jusko, W. J., & Cohen, J. L. (1972). Phenobarbital effects on cyclophosphamide pharmacokinetics in man. Cancer Research, 32(12), 2761\u20132764.", "journal-title": "Cancer Research"}, {"issue": "3", "key": "10_CR98_10", "first-page": "349", "volume": "14", "author": "DH Ho", "year": "1986", "unstructured": "Ho, D. H., et al. (1986). Clinical pharmacology of polyethylene glycol-l-asparaginase. Drug Metabolism and Disposition, 14(3), 349\u2013352.", "journal-title": "Drug Metabolism and Disposition"}, {"issue": "16", "key": "10_CR99_10", "doi-asserted-by": "publisher", "first-page": "5335", "DOI": "10.1158/1078-0432.CCR-04-0222", "volume": "10", "author": "DS Hawkins", "year": "2004", "unstructured": "Hawkins, D. S., et al. (2004). Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated l-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clinical Cancer Research, 10(16), 5335\u20135341.", "journal-title": "Clinical Cancer Research"}, {"issue": "1", "key": "10_CR100_10", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1055/s-0038-1647150", "volume": "64", "author": "N Semeraro", "year": "1990", "unstructured": "Semeraro, N., et al. (1990). Unbalanced coagulation-fibrinolysis potential during l-asparaginase therapy in children with acute lymphoblastic leukaemia. Thrombosis and Haemostasis, 64(1), 38\u201340.", "journal-title": "Thrombosis and Haemostasis"}, {"issue": "9", "key": "10_CR101_10", "doi-asserted-by": "crossref", "first-page": "1780", "DOI": "10.1200/JCO.1993.11.9.1780", "volume": "11", "author": "BL Asselin", "year": "1993", "unstructured": "Asselin, B. L., et al. (1993). Comparative pharmacokinetic studies of three asparaginase preparations. Journal of Clinical Oncology, 11(9), 1780\u20131786.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "4", "key": "10_CR102_10", "doi-asserted-by": "publisher", "first-page": "1398", "DOI": "10.1002/1097-0142(197710)40:4<1398::AID-CNCR2820400406>3.0.CO;2-#", "volume": "40", "author": "NK Ramsay", "year": "1977", "unstructured": "Ramsay, N. K., et al. (1977). The effect of l-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia. Cancer, 40(4), 1398\u20131401.", "journal-title": "Cancer"}, {"issue": "6", "key": "10_CR103_10", "doi-asserted-by": "publisher", "first-page": "1313", "DOI": "10.1002/1097-0142(197106)27:6<1313::AID-CNCR2820270606>3.0.CO;2-W", "volume": "27", "author": "HR Gralnick", "year": "1971", "unstructured": "Gralnick, H. R., & Henderson, E. (1971). Hypofibrinogenemia and coagulation factor deficiencies with l-asparaginase treatment. Cancer, 27(6), 1313\u20131320.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR104_10", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1016/S0887-8994(97)00079-9", "volume": "17", "author": "KO Bushara", "year": "1997", "unstructured": "Bushara, K. O., & Rust, R. S. (1997). Reversible MRI lesions due to pegaspargase treatment of non-Hodgkin\u2019s lymphoma. Pediatric Neurology, 17(2), 185\u2013187.", "journal-title": "Pediatric Neurology"}, {"issue": "8473", "key": "10_CR105_10", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1016/S0140-6736(86)92304-4", "volume": "1", "author": "JV Leonard", "year": "1986", "unstructured": "Leonard, J. V., & Kay, J. D. (1986). Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase. Lancet, 1(8473), 162\u2013163.", "journal-title": "Lancet"}, {"issue": "9", "key": "10_CR106_10", "doi-asserted-by": "publisher", "first-page": "2004", "DOI": "10.1002/1097-0142(19801101)46:9<2004::AID-CNCR2820460918>3.0.CO;2-S", "volume": "46", "author": "RE Harris", "year": "1980", "unstructured": "Harris, R. E., et al. (1980). Methotrexate/l-asparaginase combination chemotherapy for patients with acute leukemia in relapse: A study of 36 children. Cancer, 46(9), 2004\u20132008.", "journal-title": "Cancer"}, {"issue": "13", "key": "10_CR107_10", "first-page": "3030", "volume": "56", "author": "KC Xie", "year": "1996", "unstructured": "Xie, K. C., & Plunkett, W. (1996). Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl) adenine. Cancer Research, 56(13), 3030\u20133037.", "journal-title": "Cancer Research"}, {"issue": "6", "key": "10_CR108_10", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1016/S1567-5769(01)00056-X", "volume": "1", "author": "S Bantia", "year": "2001", "unstructured": "Bantia, S., et al. (2001). Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)\u2013a novel potent and orally active immunosuppressive agent. International Immunopharmacology, 1(6), 1199\u20131210.", "journal-title": "International Immunopharmacology"}, {"issue": "5", "key": "10_CR109_10", "doi-asserted-by": "crossref", "first-page": "995", "DOI": "10.1200/JCO.2000.18.5.995", "volume": "18", "author": "DF Kisor", "year": "2000", "unstructured": "Kisor, D. F., et al. (2000). Pharmacokinetics of nelarabine and 9-beta-d-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies. Journal of Clinical Oncology, 18(5), 995\u20131003.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "11", "key": "10_CR110_10", "doi-asserted-by": "crossref", "first-page": "3607", "DOI": "10.1200/JCO.1998.16.11.3607", "volume": "16", "author": "V Gandhi", "year": "1998", "unstructured": "Gandhi, V., et al. (1998). Compound GW506U78 in refractory hematologic malignancies: Relationship between cellular pharmacokinetics and clinical response. Journal of Clinical Oncology, 16(11), 3607\u20133615.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "6", "key": "10_CR111_10", "doi-asserted-by": "publisher", "first-page": "1056", "DOI": "10.1345/aph.1E453", "volume": "39", "author": "DF Kisor", "year": "2005", "unstructured": "Kisor, D. F. (2005). Nelarabine: A nucleoside analog with efficacy in T-cell and other leukemias. The Annals of Pharmacotherapy, 39(6), 1056\u20131063.", "journal-title": "The Annals of Pharmacotherapy"}, {"issue": "6", "key": "10_CR112_10", "doi-asserted-by": "publisher", "first-page": "1167", "DOI": "10.1200/JCO.2003.04.031", "volume": "21", "author": "HM Kantarjian", "year": "2003", "unstructured": "Kantarjian, H. M., et al. (2003). Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers. Journal of Clinical Oncology, 21(6), 1167\u20131173.", "journal-title": "Journal of Clinical Oncology"}, {"issue": "17", "key": "10_CR113_10", "first-page": "6335", "volume": "9", "author": "V Gandhi", "year": "2003", "unstructured": "Gandhi, V., et al. (2003). Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias. Clinical Cancer Research, 9(17), 6335\u20136342.", "journal-title": "Clinical Cancer Research"}, {"issue": "13", "key": "10_CR114_10", "doi-asserted-by": "publisher", "first-page": "4253", "DOI": "10.1182/blood-2005-03-1309", "volume": "106", "author": "V Gandhi", "year": "2005", "unstructured": "Gandhi, V., et al. (2005). A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood, 106(13), 4253\u20134260.", "journal-title": "Blood"}, {"issue": "7", "key": "10_CR115_10", "doi-asserted-by": "publisher", "first-page": "2379", "DOI": "10.1182/blood-2003-03-0925", "volume": "102", "author": "H Kantarjian", "year": "2003", "unstructured": "Kantarjian, H., et al. (2003). Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood, 102(7), 2379\u20132386.", "journal-title": "Blood"}, {"issue": "6 Suppl 5", "key": "10_CR116_10", "doi-asserted-by": "publisher", "first-page": "S13", "DOI": "10.1053/j.seminoncol.2007.11.002", "volume": "34", "author": "RA Larson", "year": "2007", "unstructured": "Larson, R. A. (2007). Three new drugs for acute lymphoblastic leukemia: Nelarabine, clofarabine, and forodesine. Seminars in Oncology, 34(6 Suppl 5), S13\u2013S20.", "journal-title": "Seminars in Oncology"}, {"issue": "3", "key": "10_CR117_10", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1056/NEJMct071828", "volume": "357", "author": "CA Schiffer", "year": "2007", "unstructured": "Schiffer, C. A. (2007). BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. The New England Journal of Medicine, 357(3), 258\u2013265.", "journal-title": "The New England Journal of Medicine"}, {"issue": "11", "key": "10_CR118_10", "doi-asserted-by": "publisher", "first-page": "4500", "DOI": "10.1158/0008-5472.CAN-05-0259", "volume": "65", "author": "T O\u2019Hare", "year": "2005", "unstructured": "O\u2019Hare, T., et al. (2005). In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Research, 65(11), 4500\u20134505.", "journal-title": "Cancer Research"}, {"issue": "14", "key": "10_CR119_10", "doi-asserted-by": "publisher", "first-page": "1031", "DOI": "10.1056/NEJM200104053441401", "volume": "344", "author": "BJ Druker", "year": "2001", "unstructured": "Druker, B. J., et al. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. The New England Journal of Medicine, 344(14), 1031\u20131037.", "journal-title": "The New England Journal of Medicine"}, {"issue": "5", "key": "10_CR120_10", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1038/nm0596-561", "volume": "2", "author": "BJ Druker", "year": "1996", "unstructured": "Druker, B. J., et al. (1996). Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Natural Medicines, 2(5), 561\u2013566.", "journal-title": "Natural Medicines"}, {"issue": "24", "key": "10_CR121_10", "doi-asserted-by": "publisher", "first-page": "2594", "DOI": "10.1056/NEJMe068073", "volume": "354", "author": "BJ Druker", "year": "2006", "unstructured": "Druker, B. J. (2006). Circumventing resistance to kinase-inhibitor therapy. The New England Journal of Medicine, 354(24), 2594\u20132596.", "journal-title": "The New England Journal of Medicine"}, {"issue": "45", "key": "10_CR122_10", "doi-asserted-by": "publisher", "first-page": "16870", "DOI": "10.1073/pnas.0606509103", "volume": "103", "author": "Y Hu", "year": "2006", "unstructured": "Hu, Y., et al. (2006). Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph + leukemia in mice. Proceedings of the National Academy of Sciences of the United States of America, 103(45), 16870\u201316875.", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America"}, {"issue": "13", "key": "10_CR123_10", "doi-asserted-by": "publisher", "first-page": "4027", "DOI": "10.1158/1078-0432.CCR-07-5015", "volume": "14", "author": "MW Deininger", "year": "2008", "unstructured": "Deininger, M. W. (2008). Nilotinib. Clinical Cancer Research, 14(13), 4027\u20134031.", "journal-title": "Clinical Cancer Research"}, {"issue": "13", "key": "10_CR124_10", "doi-asserted-by": "publisher", "first-page": "4941", "DOI": "10.1158/1078-0432.CCR-04-2601", "volume": "11", "author": "M Golemovic", "year": "2005", "unstructured": "Golemovic, M., et al. (2005). AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia. Clinical Cancer Research, 11(13), 4941\u20134947.", "journal-title": "Clinical Cancer Research"}, {"issue": "1", "key": "10_CR125_10", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.2165/00063030-200822010-00007", "volume": "22", "author": "SJ Keam", "year": "2008", "unstructured": "Keam, S. J. (2008). Dasatinib: In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. BioDrugs, 22(1), 59\u201369.", "journal-title": "BioDrugs"}, {"issue": "11", "key": "10_CR126_10", "doi-asserted-by": "publisher", "first-page": "2289", "DOI": "10.1016/j.clinthera.2007.11.005", "volume": "29", "author": "M Steinberg", "year": "2007", "unstructured": "Steinberg, M. (2007). Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Clinical Therapeutics, 29(11), 2289\u20132308.", "journal-title": "Clinical Therapeutics"}, {"issue": "17", "key": "10_CR127_10", "doi-asserted-by": "publisher", "first-page": "5325", "DOI": "10.1158/1078-0432.CCR-08-0308", "volume": "14", "author": "M Hazarika", "year": "2008", "unstructured": "Hazarika, M., et al. (2008). Tasigna for chronic and accelerated phase Philadelphia chromosome\u2013positive chronic myelogenous leukemia resistant to or intolerant of imatinib. Clinical Cancer Research, 14(17), 5325\u20135331.", "journal-title": "Clinical Cancer Research"}, {"issue": "2", "key": "10_CR128_10", "doi-asserted-by": "publisher", "first-page": "352", "DOI": "10.1158/1078-0432.CCR-07-4175", "volume": "14", "author": "M Brave", "year": "2008", "unstructured": "Brave, M., et al. (2008). Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clinical Cancer Research, 14(2), 352\u2013359.", "journal-title": "Clinical Cancer Research"}, {"issue": "24", "key": "10_CR129_10", "doi-asserted-by": "publisher", "first-page": "2531", "DOI": "10.1056/NEJMoa055229", "volume": "354", "author": "M Talpaz", "year": "2006", "unstructured": "Talpaz, M., et al. (2006). Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. The New England Journal of Medicine, 354(24), 2531\u20132541.", "journal-title": "The New England Journal of Medicine"}, {"issue": "24", "key": "10_CR130_10", "doi-asserted-by": "publisher", "first-page": "2542", "DOI": "10.1056/NEJMoa055104", "volume": "354", "author": "H Kantarjian", "year": "2006", "unstructured": "Kantarjian, H., et al. (2006). Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. The New England Journal of Medicine, 354(24), 2542\u20132551.", "journal-title": "The New England Journal of Medicine"}, {"issue": "10", "key": "10_CR131_10", "doi-asserted-by": "publisher", "first-page": "3547", "DOI": "10.1182/blood.V99.10.3547", "volume": "99", "author": "HM Kantarjian", "year": "2002", "unstructured": "Kantarjian, H. M., et al. (2002). Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood, 99(10), 3547\u20133553.", "journal-title": "Blood"}, {"key": "10_CR132_10", "unstructured": "Prescribing Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals Corporation [cited; Available from: \n                  www.FDA.gov/cder/foi\n                  \n                ]."}, {"key": "10_CR133_10", "unstructured": "Prescribing Information. Tasigna (nilotinib). Novartis Pharmaceuticals Corporation [cited; Available from: \n                  www.fda.gov/cder/foi\n                  \n                ]."}, {"key": "10_CR134_10", "unstructured": "Prescribing Information: Sprycell (Dasatinib). Micromedix [cited; Available from: \n                  www.fda/gov/cder/foi/label/2006/021986LbL.pdr\n                  \n                ]."}, {"issue": "6", "key": "10_CR135_10", "doi-asserted-by": "publisher", "first-page": "1267", "DOI": "10.1038/sj.leu.2404638", "volume": "21", "author": "C Brendel", "year": "2007", "unstructured": "Brendel, C., et al. (2007). Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia, 21(6), 1267\u20131275.", "journal-title": "Leukemia"}, {"issue": "2", "key": "10_CR136_10", "doi-asserted-by": "publisher", "first-page": "824", "DOI": "10.1124/jpet.103.055574", "volume": "307", "author": "A Hamada", "year": "2003", "unstructured": "Hamada, A., et al. (2003). Interaction of imatinib mesilate with human P-glycoprotein. The Journal of Pharmacology and Experimental Therapeutics, 307(2), 824\u2013828.", "journal-title": "The Journal of Pharmacology and Experimental Therapeutics"}, {"issue": "4", "key": "10_CR137_10", "doi-asserted-by": "publisher", "first-page": "1005", "DOI": "10.1182/blood-2008-02-140665", "volume": "112", "author": "K Porkka", "year": "2008", "unstructured": "Porkka, K., et al. (2008). Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood, 112(4), 1005\u20131012.", "journal-title": "Blood"}, {"issue": "2", "key": "10_CR138_10", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1080/10428190310001593184", "volume": "45", "author": "S Bujassoum", "year": "2004", "unstructured": "Bujassoum, S., Rifkind, J., & Lipton, J. H. (2004). Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy. Leukaemia & Lymphoma, 45(2), 401\u2013403.", "journal-title": "Leukaemia & Lymphoma"}, {"issue": "48", "key": "10_CR139_10", "doi-asserted-by": "crossref", "first-page": "6608", "DOI": "10.3748/wjg.v13.i48.6608", "volume": "13", "author": "E Ridruejo", "year": "2007", "unstructured": "Ridruejo, E., et al. (2007). Imatinib-induced fatal acute liver failure. World Journal of Gastroenterology, 13(48), 6608\u20136611.", "journal-title": "World Journal of Gastroenterology"}], "container-title": ["Adult Acute Lymphocytic Leukemia"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60761-707-5_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T06:27:23Z", "timestamp": 1553236043000}, "score": 31.971018, "issued": {"date-parts": [[2010, 10, 19]]}, "ISBN": ["9781607617068", "9781607617075"], "references-count": 139, "URL": "http://dx.doi.org/10.1007/978-1-60761-707-5_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T16:59:39Z", "timestamp": 1574182779886}, "reference-count": 1, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 2, 1]], "date-time": "2006-02-01T00:00:00Z", "timestamp": 1138752000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[2006, 2]]}, "DOI": "10.1016/j.cancergencyto.2005.06.011", "type": "journal-article", "created": {"date-parts": [[2006, 2, 19]], "date-time": "2006-02-19T12:15:17Z", "timestamp": 1140351317000}, "page": "79-80", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A cryptic chromosome 19 abnormality in a patient with Ph-positive acute lymphoblastic leukemia"], "prefix": "10.1016", "volume": "165", "author": [{"given": "Roland", "family": "Berger", "sequence": "first", "affiliation": []}, {"given": "Maryvonne", "family": "Busson", "sequence": "additional", "affiliation": []}, {"given": "Serge P.", "family": "Romana", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165460805003225?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165460805003225?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 18]], "date-time": "2019-01-18T12:22:58Z", "timestamp": 1547814178000}, "score": 31.206863, "issued": {"date-parts": [[2006, 2]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[2006, 2]]}, "issue": "1"}, "alternative-id": ["S0165460805003225"], "URL": "http://dx.doi.org/10.1016/j.cancergencyto.2005.06.011", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:18:28Z", "timestamp": 1574104708145}, "reference-count": 73, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 3, 1]], "date-time": "1997-03-01T00:00:00Z", "timestamp": 857174400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[1997, 3]]}, "DOI": "10.1016/s0165-4608(96)00351-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:31:54Z", "timestamp": 1027636314000}, "page": "8-12", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Acute lymphoblastic leukemia and chromosome 21"], "prefix": "10.1016", "volume": "94", "author": [{"given": "Roland", "family": "Berger", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165460896003512?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165460896003512?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T03:56:42Z", "timestamp": 1555646202000}, "score": 31.067665, "issued": {"date-parts": [[1997, 3]]}, "references-count": 73, "journal-issue": {"published-print": {"date-parts": [[1997, 3]]}, "issue": "1"}, "alternative-id": ["S0165460896003512"], "URL": "http://dx.doi.org/10.1016/s0165-4608(96)00351-2", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:18:40Z", "timestamp": 1575191920007}, "reference-count": 16, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 12, 8]], "date-time": "2005-12-08T00:00:00Z", "timestamp": 1134000000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2006, 2]]}, "DOI": "10.1038/sj.leu.2404063", "type": "journal-article", "created": {"date-parts": [[2005, 12, 8]], "date-time": "2005-12-08T08:07:10Z", "timestamp": 1134029230000}, "page": "319-321", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements"], "prefix": "10.1038", "volume": "20", "author": [{"given": "R", "family": "Berger", "sequence": "first", "affiliation": []}, {"name": "on behalf of the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Busson", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Baranger", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "H\u00e9lias", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Lessard", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Speleman", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 12, 8]]}, "reference": [{"key": "BF2404063_CR1", "first-page": "705", "volume": "47", "author": "JD Rowley", "year": "1976", "unstructured": "Rowley JD, Potter D . Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976; 47: 705\u2013721.", "journal-title": "Blood"}, {"key": "BF2404063_CR2", "doi-asserted-by": "publisher", "first-page": "748", "DOI": "10.1002/1097-0142(197608)38:2<748::AID-CNCR2820380218>3.0.CO;2-U", "volume": "38", "author": "M Oshimura", "year": "1976", "unstructured": "Oshimura M, Hayata I, Kakati S, Sandberg AA . Chromosomes and causation of human cancer and leukemia. XVII. Banding studies in acute myeloblastic leukemia (AML). Cancer 1976; 38: 748\u2013761.", "journal-title": "Cancer"}, {"key": "BF2404063_CR3", "unstructured": "Mitelman F, Johansson B, Mertens F (eds). Mitelman Database of Chromosome Aberrations in Cancer (2005). \n                    http://cgap.nci.nih.gov/Chromosomes/Mitelman\n                    \n                  ."}, {"key": "BF2404063_CR4", "first-page": "42", "volume": "3", "author": "SC Raimondi", "year": "1989", "unstructured": "Raimondi SC, Dub\u00e9 I, Valentine MB, Mirro Jr J, Watt HJ, Larson RA et al. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 1989; 3: 42\u201347.", "journal-title": "Leukemia"}, {"key": "BF2404063_CR5", "first-page": "265", "volume": "12", "author": "N Yoneda-Kato", "year": "1996", "unstructured": "Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NMP-MLF1. Oncogene 1996; 12: 265\u2013275.", "journal-title": "Oncogene"}, {"key": "BF2404063_CR6", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1002/gcc.2870090307", "volume": "9", "author": "SP Romana", "year": "1994", "unstructured": "Romana SP, Le Coniat M, Berger R . t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 1994; 9: 186\u2013191.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2404063_CR7", "first-page": "574", "volume": "92", "author": "N Pallisgaard", "year": "1998", "unstructured": "Pallisgaard N, Hokland P, Riish\u00f8j DC, Pedersen B, J\u00f8rgensen P . Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574\u2013588.", "journal-title": "Blood"}, {"key": "BF2404063_CR8", "first-page": "1883", "volume": "10", "author": "B Pedersen", "year": "1996", "unstructured": "Pedersen B . Anatomy of the 5q-deletion: different sex ratios and deleted 5q bands in MDS and AML. Leukemia 1996; 10: 1883\u20131890.", "journal-title": "Leukemia"}, {"key": "BF2404063_CR9", "first-page": "82", "volume": "75", "author": "L Nagarajan", "year": "1990", "unstructured": "Nagarajan L, Lange B, Cannizzaro L, Finan J, Nowell PC, Huebner K . Molecular anatomy of a 5q interstitial deletion. Blood 1990; 75: 82\u201387.", "journal-title": "Blood"}, {"key": "BF2404063_CR10", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1016/0165-4608(94)90021-3", "volume": "74", "author": "L Nagarajan", "year": "1994", "unstructured": "Nagarajan L, Zhao L, Lu X, Warrington J, Wasmuth JJ, Siciliano M et al. 5q-chromosome: evidence for complex interstitial breaks in a case of refractory anemia with excess of blasts. Cancer Genet Cytogenet 1994; 74: 8\u201312.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2404063_CR11", "doi-asserted-by": "publisher", "first-page": "1757", "DOI": "10.1038/sj.leu.2401897", "volume": "14", "author": "N Matsumoto", "year": "2000", "unstructured": "Matsumoto N, Yoneda-Kato N, Iguchi T, Kishimoto Y, Kyo Y, Sawada H et al. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome. Leukemia 2000; 14: 1757\u20131765.", "journal-title": "Leukemia"}, {"key": "BF2404063_CR12", "doi-asserted-by": "publisher", "first-page": "809", "DOI": "10.1016/S0046-8177(03)00251-X", "volume": "34", "author": "DA Arber", "year": "2003", "unstructured": "Arber DA, Chang KL, Lyda MH, Bedell V, Spielberger R, Slovak ML . Detection of NPM/MLF1 fusion in t(3;5)-positive acute myloid leukemia and myelodysplasia. Hum Pathol 2003; 34: 809\u2013813.", "journal-title": "Hum Pathol"}, {"key": "BF2404063_CR13", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1038/nature03915", "volume": "437", "author": "S Grisendi", "year": "2005", "unstructured": "Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005; 437: 147\u2013153.", "journal-title": "Nature"}, {"key": "BF2404063_CR14", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1182/blood-2005-02-0560", "volume": "106", "author": "M Alcalay", "year": "2005", "unstructured": "Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, et al., for the Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto (GIMEMA) Acute leukemia Working Party. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899\u2013902.", "journal-title": "Blood"}, {"key": "BF2404063_CR15", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1182/blood-2005-03-0899", "volume": "106", "author": "G Cazzaniga", "year": "2005", "unstructured": "Cazzaniga G, Dell\u2019Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 2005; 106: 1419\u20131422.", "journal-title": "Blood"}, {"key": "BF2404063_CR16", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1056/NEJMoa041974", "volume": "352", "author": "B Falini", "year": "2005", "unstructured": "Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al., for the GIMEMA Acute Leukemia Working Party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254\u2013266.", "journal-title": "N Engl J Med"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2404063.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404063", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404063.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T04:08:58Z", "timestamp": 1552882138000}, "score": 30.952784, "issued": {"date-parts": [[2005, 12, 8]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2006, 2]]}, "issue": "2"}, "alternative-id": ["BF2404063"], "URL": "http://dx.doi.org/10.1038/sj.leu.2404063", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T21:43:18Z", "timestamp": 1576532598022}, "reference-count": 64, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7123, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Cell. Physiol."], "published-print": {"date-parts": [[1996, 3]]}, "DOI": "10.1002/(sici)1097-4652(199603)166:3<618::aid-jcp17>3.0.co;2-2", "type": "journal-article", "created": {"date-parts": [[2002, 9, 10]], "date-time": "2002-09-10T23:50:02Z", "timestamp": 1031701802000}, "page": "618-630", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: Studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)"], "prefix": "10.1002", "volume": "166", "author": [{"given": "Z.", "family": "Estrov", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Talpaz", "sequence": "additional", "affiliation": []}, {"given": "T. F.", "family": "Zipf", "sequence": "additional", "affiliation": []}, {"given": "H. M.", "family": "Kantarjian", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Ku", "sequence": "additional", "affiliation": []}, {"given": "M. V.", "family": "Ouspenskaia", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Hirsch-Ginsberg", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Huh", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Yee", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kurzrock", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB1", "author": "Aggarwal", "volume": "262", "first-page": "10", "year": "1987", "journal-title": "J. Biol. Chem."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB2", "author": "Annini", "volume": "8", "first-page": "664", "year": "1994", "journal-title": "Leukemia"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB3", "author": "Arnold", "volume": "35", "first-page": "1588", "year": "1989", "journal-title": "Clin. Chem."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB4", "author": "Bennett", "volume": "33", "first-page": "451", "year": "1976", "journal-title": "Br. J. Haematol.", "DOI": "10.1111/j.1365-2141.1976.tb03563.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB5", "author": "Biondi", "volume": "73", "first-page": "1279", "year": "1989", "journal-title": "Blood", "DOI": "10.1182/blood.V73.5.1279.1279", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB6", "author": "Buchner", "volume": "78", "first-page": "1190", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V78.5.1190.1190", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB7", "author": "Chan", "volume": "325", "first-page": "635", "year": "1987", "journal-title": "Nature (Lond.)", "DOI": "10.1038/325635a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB8", "author": "Clark", "volume": "235", "first-page": "85", "year": "1987", "journal-title": "Science", "DOI": "10.1126/science.3541203", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB9", "author": "Cohen", "volume": "78", "first-page": "94", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V78.1.94.94", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB10", "author": "Cordingley", "volume": "1", "first-page": "969", "year": "1988", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(88)91782-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB11", "author": "Dhingra", "volume": "77", "first-page": "238", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V77.2.238.238", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB12", "author": "DiPersio", "volume": "263", "first-page": "1834", "year": "1988", "journal-title": "J. Biol. Chem."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB13", "author": "Drach", "volume": "16", "first-page": "79", "year": "1994", "journal-title": "Leuk. Lymphoma", "DOI": "10.3109/10428199409114143", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB14", "author": "Erikson", "volume": "83", "first-page": "1807", "year": "1986", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.83.6.1807", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB15", "author": "Estey", "volume": "83", "first-page": "2015", "year": "1994", "journal-title": "Blood", "DOI": "10.1182/blood.V83.8.2015.2015", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB16", "author": "Estrov", "volume": "48", "first-page": "5901", "year": "1988", "journal-title": "Cancer Res."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB17", "author": "Estrov", "volume": "315", "first-page": "538", "year": "1986", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198608283150902", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB18", "author": "Estrov", "volume": "10", "first-page": "288", "year": "1988", "journal-title": "Am. J. Pediatr. Hematol. Oncol.", "DOI": "10.1097/00043426-198824000-00003", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB19", "author": "Estrov", "volume": "78", "first-page": "1476", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V78.6.1476.1476", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB20", "author": "Estrov", "volume": "79", "first-page": "1938", "year": "1992", "journal-title": "Blood", "DOI": "10.1182/blood.V79.8.1938.1938", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB21", "author": "Estrov", "volume": "3", "first-page": "306", "year": "1993a", "journal-title": "FORUM Trends Exp. Clin. Med."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB22", "author": "Estrov", "volume": "53", "first-page": "3289", "year": "1993b", "journal-title": "Cancer Res."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB23", "author": "Estrov", "volume": "177", "first-page": "763", "year": "1993c", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.177.3.763", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB24", "author": "Estrov", "volume": "8", "first-page": "46", "year": "1994", "journal-title": "Leukemia"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB25", "author": "Feinberg", "volume": "137", "first-page": "226", "year": "1984", "journal-title": "Anal. Biochem."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB26", "author": "Ferrajoli", "volume": "67", "first-page": "277", "year": "1993", "journal-title": "Ann. Hematol.", "DOI": "10.1007/BF01696347", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB27", "author": "Freedman", "volume": "81", "first-page": "3068", "year": "1993", "journal-title": "Blood", "DOI": "10.1182/blood.V81.11.3068.3068", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB28", "author": "Freeman", "volume": "83", "first-page": "1512", "year": "1989", "journal-title": "J. Clin. Invest.", "DOI": "10.1172/JCI114046", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB29", "author": "Gearing", "volume": "8", "first-page": "3667", "year": "1989", "journal-title": "EMBO J.", "DOI": "10.1002/j.1460-2075.1989.tb08541.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB30", "author": "Graham", "volume": "14", "first-page": "291", "year": "1966", "journal-title": "J. Histochem. Cytochem.", "DOI": "10.1177/14.4.291", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB31", "author": "Griffin", "volume": "1", "first-page": "81", "year": "1987", "journal-title": "Hematol. Pathol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB32", "author": "Grigg", "volume": "12", "first-page": "431", "year": "1993", "journal-title": "Bone Marrow Transplant"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB33", "author": "Groffen", "volume": "36", "first-page": "93", "year": "1984", "journal-title": "Cell", "DOI": "10.1016/0092-8674(84)90077-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB34", "author": "Han", "volume": "71", "first-page": "299", "year": "1989", "journal-title": "Br. J. Haematol.", "DOI": "10.1111/j.1365-2141.1989.tb04275.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB35", "author": "Hayashi", "volume": "61", "first-page": "712", "year": "1988", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19880215)61:4<712::AID-CNCR2820610414>3.0.CO;2-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB36", "author": "Hearing", "volume": "81", "first-page": "4373", "year": "1984", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.81.14.4373", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB37", "author": "International System for Human Cytogenetic Nomenclature", "volume": "21", "first-page": "309", "year": "1978", "journal-title": "Cell Genet.", "DOI": "10.1159/000130909", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB38", "author": "Higuchi", "volume": "204", "first-page": "53", "year": "1992", "journal-title": "Anal. Biochem.", "DOI": "10.1016/0003-2697(92)90138-W", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB39", "author": "Kantarjian", "volume": "78", "first-page": "2411", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V78.9.2411.2411", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB40", "author": "Kawano", "volume": "332", "first-page": "83", "year": "1988", "journal-title": "Nature", "DOI": "10.1038/332083a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB41", "author": "Kawasaki", "volume": "85", "first-page": "5698", "year": "1988", "journal-title": "Proc. Natl. Acad. Sci. U.S.A.", "DOI": "10.1073/pnas.85.15.5698", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB42", "author": "Kloetzer", "volume": "140", "first-page": "230", "year": "1985", "journal-title": "Virology", "DOI": "10.1016/0042-6822(85)90361-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB43", "author": "Kurzrock", "volume": "105", "first-page": "673", "year": "1986", "journal-title": "Ann. Intern. Med.", "DOI": "10.7326/0003-4819-105-5-673", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB44", "author": "Kurzrock", "volume": "70", "first-page": "233", "year": "1987a", "journal-title": "Blood", "DOI": "10.1182/blood.V70.1.233.233", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB45", "author": "Kurzrock", "volume": "324", "first-page": "631", "year": "1987b", "journal-title": "Nature (Lond.)", "DOI": "10.1038/325631a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB46", "author": "Kurzrock", "volume": "319", "first-page": "990", "year": "1988", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198810133191506", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB47", "author": "LeMaister", "volume": "2", "first-page": "79", "year": "1988", "journal-title": "Hematol. Pathol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB48", "author": "Malejczyk", "volume": "149", "first-page": "2702", "year": "1992", "journal-title": "J. Immunol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB49", "author": "Michiel", "volume": "3", "first-page": "3", "year": "1992", "journal-title": "Semin. Cancer Biol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB50", "author": "Mirro", "volume": "66", "first-page": "1115", "year": "1986", "journal-title": "Blood", "DOI": "10.1182/blood.V66.5.1115.1115", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB51", "author": "Neame", "volume": "65", "first-page": "142", "year": "1985", "journal-title": "Blood", "DOI": "10.1182/blood.V65.1.142.bloodjournal651142", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB52", "author": "Pistoia", "volume": "136", "first-page": "1688", "year": "1986", "journal-title": "J. Immunol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB53", "author": "Roberts", "volume": "343", "first-page": "331", "year": "1994", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(94)91166-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB54", "author": "Rodenhuis", "volume": "313", "first-page": "51", "year": "1985", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198507043130117", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB55", "author": "Sakai", "volume": "166", "first-page": "1597", "year": "1987", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.166.5.1597", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB56", "author": "Sambrook", "first-page": "187", "year": "1989", "unstructured": "and (1989) Molecular Cloning\u2014A Laboratory Manual. 2nd ed. Cold Spring Harbor Press, New York, N. Y., pp. 187-212.", "volume-title": "Molecular Cloning\u2014A Laboratory Manual"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB57", "author": "Scala", "volume": "132", "first-page": "115", "year": "1986", "journal-title": "Curr. Top. Microbiol. Immunol."}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB58", "author": "Seabright", "volume": "2", "first-page": "971", "year": "1971", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(71)90287-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB59", "author": "Southern", "volume": "98", "first-page": "503", "year": "1975", "journal-title": "J. Mol. Biol.", "DOI": "10.1016/S0022-2836(75)80083-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB60", "author": "Sporn", "volume": "313", "first-page": "745", "year": "1985", "journal-title": "Nature", "DOI": "10.1038/313745a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB61", "author": "Sporn", "volume": "303", "first-page": "878", "year": "1980", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198010093031511", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB62", "author": "Stass", "volume": "64", "first-page": "701", "year": "1984", "journal-title": "Blood", "DOI": "10.1182/blood.V64.3.701.701", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB63", "author": "Touw", "volume": "75", "first-page": "2097", "year": "1990", "journal-title": "Blood", "DOI": "10.1182/blood.V75.11.2097.2097", "doi-asserted-by": "crossref"}, {"key": "10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2-BIB64", "author": "Tsuchiya", "volume": "77", "first-page": "411", "year": "1991", "journal-title": "Blood", "DOI": "10.1182/blood.V77.2.411a.411a", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Cellular Physiology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-4652(199603)166:3%3C618::AID-JCP17%3E3.0.CO;2-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-4652(199603)166:3%3C618::AID-JCP17%3E3.0.CO;2-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 15]], "date-time": "2019-12-15T11:01:46Z", "timestamp": 1576407706000}, "score": 30.199242, "issued": {"date-parts": [[1996, 3]]}, "references-count": 64, "journal-issue": {"published-print": {"date-parts": [[1996, 3]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/(sici)1097-4652(199603)166:3<618::aid-jcp17>3.0.co;2-2", "relation": {"cites": []}, "ISSN": ["0021-9541", "1097-4652"], "issn-type": [{"value": "0021-9541", "type": "print"}, {"value": "1097-4652", "type": "electronic"}], "subject": ["Clinical Biochemistry", "Cell Biology", "Physiology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T10:18:20Z", "timestamp": 1575281900913}, "publisher-location": "Dordrecht", "reference-count": 13, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401090025", "type": "print"}, {"value": "9789400956704", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1984, 1, 1]], "date-time": "1984-01-01T00:00:00Z", "timestamp": 441763200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1984]]}, "DOI": "10.1007/978-94-009-5670-4_19", "type": "book-chapter", "created": {"date-parts": [[2013, 9, 27]], "date-time": "2013-09-27T19:16:03Z", "timestamp": 1380309363000}, "page": "255-264", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Autologous Bone Marrow Transplantation in Calla Positive Acute Lymphoblastic Leukemia"], "prefix": "10.1007", "author": [{"given": "S. E.", "family": "Sallan", "sequence": "first", "affiliation": []}, {"given": "R. C.", "family": "Bast", "sequence": "additional", "affiliation": []}, {"given": "J. M.", "family": "Lipton", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Ritz", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "19_CR1", "first-page": "297", "volume": "61", "author": "A Inati", "year": "1983", "unstructured": "Inati A, Sallan SE, Cassady JR et al. 1983. Efficacy and morbidity of central nervous system \u201cprophylaxis\u201d in childhood acute lymphoblastic leukemia: Eight years\u2019 experience with cranial irradiation and intrathecal methotrexate. Blood 61, 297\u2013303.", "journal-title": "Blood"}, {"key": "19_CR2", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.1200/JCO.1983.1.8.462", "volume": "1", "author": "P Schauer", "year": "1983", "unstructured": "Schauer P, Arlin ZA, Mertelsmann R et al. 1983. Treatment of acute lymphoblastic leukemia in adults: Results of the L10 and L10M protocols. J Clin Oncol 1, 462\u2013470.", "journal-title": "J Clin Oncol"}, {"key": "19_CR3", "first-page": "93", "volume": "65", "author": "DG Poplack", "year": "1981", "unstructured": "Poplack DG, Reaman GH, Wesley R. 1981. Treatment of acute lymphoblastic leukemia in relapse: Efficacy of a four-drug reinduction regimen. Can Treat Rep 65, 93\u201396.", "journal-title": "Can Treat Rep"}, {"key": "19_CR4", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1002/mpo.2950090507", "volume": "9", "author": "SE Sallan", "year": "1981", "unstructured": "Sallan SE, Hitchcock-Bryan S. 1981. Relapse in childhood acute lymphoblastic leukemia after elective cessation of initial treatment: Failure of subsequent treatment. Med Ped Oncol 9, 455\u2013462.", "journal-title": "Med Ped Oncol"}, {"key": "19_CR5", "doi-asserted-by": "publisher", "first-page": "2528", "DOI": "10.1001/jama.1983.03330420074041", "volume": "249", "author": "ED Thomas", "year": "1983", "unstructured": "Thomas ED. 1983. Bone marrow transplantation: A lifesaving applied art. J Amer Med Assn 249, 2528\u20132536.", "journal-title": "J Amer Med Assn"}, {"key": "19_CR6", "first-page": "381", "volume": "62", "author": "R Dinsmore", "year": "1983", "unstructured": "Dinsmore R, Kirkpatrick D, Flomenberg N et al. 1983. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 62, 381\u2013388.", "journal-title": "Blood"}, {"key": "19_CR7", "doi-asserted-by": "publisher", "first-page": "846", "DOI": "10.1056/NEJM198110083051502", "volume": "305", "author": "FL Johnson", "year": "1981", "unstructured": "Johnson FL, Thomas ED, Clark BS et al. 1981. A comparison of bone marrow transplantation with chemotherapy for childre with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 305, 846\u2013851.", "journal-title": "N Engl J Med"}, {"key": "19_CR8", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1016/S0140-6736(82)91686-5", "volume": "2", "author": "J Ritz", "year": "1982", "unstructured": "Ritz J, Sallan SE, Bast RC et al. 1982. Autologous bone marrow transplantation in CALLA positive acute lymphoblastic leukaemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 2, 60\u201362.", "journal-title": "Lancet"}, {"key": "19_CR9", "first-page": "1389", "volume": "43", "author": "RC Bast", "year": "1983", "unstructured": "Bast RC, Ritz J, Lipton JM et al. 1983. Elimination of leukemic cells from the human bone marrow using monoclonal antibody and complement. Cancer Res 43, 1389\u20131394.", "journal-title": "Cancer Res"}, {"key": "19_CR10", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1038/283583a0", "volume": "283", "author": "J Ritz", "year": "1980", "unstructured": "Ritz J, Pesando JM, Notis-McConarty J et al. 1980. A monoclonal antibody to human acute lymphoblastic leukaemic antigen. Nature 283, 583\u2013585.", "journal-title": "Nature"}, {"key": "19_CR11", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1016/0008-8749(81)90470-6", "volume": "64", "author": "T Herchend", "year": "1981", "unstructured": "Herchend T, Nadler LM, Pesando JM, Reinherz EL, Schlossman SF, Ritz J. 1981. Expression of a 26, 000 dalton glycoprotein on activated human T-cells. Cell Immunol 64, 192.", "journal-title": "Cell Immunol"}, {"key": "19_CR12", "first-page": "223", "volume": "24", "author": "RC Bast Jr", "year": "1983", "unstructured": "Bast RC Jr, DeFabritiis P, Maver C et al. 1983. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement (C\u2019). Amer Assn Can Res 24, 223.", "journal-title": "Amer Assn Can Res"}, {"key": "19_CR13", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1200/JCO.1983.1.8.471", "volume": "1", "author": "G Rivera", "year": "1983", "unstructured": "Rivera G, George SL, Bowman WP et al. 1983. Second centra. nervous system prophylaxis in children with acute lymphoblas tic leukemia who relapse after elective cessation of therapy J Clin Oncol 1, 471\u2013476.", "journal-title": "J Clin Oncol"}], "container-title": ["Minimal Residual Disease in Acute Leukemia"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-94-009-5670-4_19", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T15:39:28Z", "timestamp": 1558107568000}, "score": 30.075531, "issued": {"date-parts": [[1984]]}, "ISBN": ["9789401090025", "9789400956704"], "references-count": 13, "URL": "http://dx.doi.org/10.1007/978-94-009-5670-4_19", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:13:02Z", "timestamp": 1575313982230}, "reference-count": 25, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 10, 16]], "date-time": "2008-10-16T00:00:00Z", "timestamp": 1224115200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1038/leu.2008.278", "type": "journal-article", "created": {"date-parts": [[2008, 10, 16]], "date-time": "2008-10-16T09:46:52Z", "timestamp": 1224150412000}, "page": "125-133", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia"], "prefix": "10.1038", "volume": "23", "author": [{"given": "C", "family": "Graux", "sequence": "first", "affiliation": []}, {"name": "on behalf of the GFCH (Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique) and the BCGHO (Belgian Cytogenetic Group for Hematology and Oncology)", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Stevens-Kroef", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Lafage", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "C J", "family": "Harrison", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Mugneret", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Bahloula", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Struski", "sequence": "additional", "affiliation": []}, {"given": "M J", "family": "Gr\u00e9goire", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Nadal", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Lippert", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Taviaux", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Simons", "sequence": "additional", "affiliation": []}, {"given": "R P", "family": "Kuiper", "sequence": "additional", "affiliation": []}, {"given": "A V", "family": "Moorman", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Barber", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Bosly", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Michaux", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Vandenberghe", "sequence": "additional", "affiliation": []}, {"given": "I", "family": "Lahortiga", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "De Keersmaecker", "sequence": "additional", "affiliation": []}, {"given": "I", "family": "Wlodarska", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Cools", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "H A", "family": "Poirel", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 10, 16]]}, "reference": [{"key": "BFleu2008278_CR1", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1146/annurev.immunol.22.012703.104753", "volume": "22", "author": "S Wong", "year": "2004", "unstructured": "Wong S, Witte ON . The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 2004; 22: 247\u2013306.", "journal-title": "Annu Rev Immunol"}, {"key": "BFleu2008278_CR2", "doi-asserted-by": "publisher", "first-page": "1535", "DOI": "10.1056/NEJMra023001", "volume": "350", "author": "CH Pui", "year": "2004", "unstructured": "Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.", "journal-title": "N Engl J Med"}, {"key": "BFleu2008278_CR3", "doi-asserted-by": "publisher", "first-page": "642", "DOI": "10.1309/B4NVER1AJJ84CTUU", "volume": "127", "author": "CP Soupir", "year": "2007", "unstructured": "Soupir CP, Vergilio JA, Dal Cin P, Muzikansky A, Kantarjian H, Jones D et al. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 2007; 127: 642\u2013650.", "journal-title": "Am J Clin Pathol"}, {"key": "BFleu2008278_CR4", "first-page": "2375", "volume": "88", "author": "JV Melo", "year": "1996", "unstructured": "Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375\u20132384.", "journal-title": "Blood"}, {"key": "BFleu2008278_CR5", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1002/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1", "volume": "30", "author": "H Van Limbergen", "year": "2001", "unstructured": "Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, H\u00e4hlen K, Poppe B et al. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosomes Cancer 2001; 30: 274\u2013282.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BFleu2008278_CR6", "doi-asserted-by": "publisher", "first-page": "2220", "DOI": "10.1038/sj.leu.2404773", "volume": "21", "author": "E De Braekeleer", "year": "2007", "unstructured": "De Braekeleer E, Douet-Guilbert N, Le Bris M-J, Berthou C, Morel F, De Braekeleer M . A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia. Leukemia 2007; 21: 2220\u20132221.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR7", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1038/sj.leu.2403595", "volume": "19", "author": "H Quentmeier", "year": "2005", "unstructured": "Quentmeier H, Cools J, MacLeod RA, Marynen P, Uphoff CC, Drexler HG et al. e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia. Leukemia 2005; 19: 295\u2013296.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR8", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.1038/sj.leu.2403357", "volume": "18", "author": "KE Barber", "year": "2004", "unstructured": "Barber KE, Martineau M, Harewood L, Stewart M, Cameron E, Strefford JC et al. Amplification of the ABL gene in T cell acute lymphoblastic leukemia. Leukemia 2004; 18: 1153\u20131156.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR9", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.1038/ng1425", "volume": "36", "author": "C Graux", "year": "2004", "unstructured": "Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084\u20131089.", "journal-title": "Nat Genet"}, {"key": "BFleu2008278_CR10", "doi-asserted-by": "publisher", "first-page": "468", "DOI": "10.1038/sj.leu.2403654", "volume": "19", "author": "P Ballerini", "year": "2005", "unstructured": "Ballerini P, Busson M, Fasola S, van den Akker J, Lapillonne H, Romana SP et al. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance. Leukemia 2005; 19: 468\u2013470.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR11", "doi-asserted-by": "publisher", "first-page": "4849", "DOI": "10.1182/blood-2004-12-4897", "volume": "105", "author": "K De Keersmaecker", "year": "2005", "unstructured": "De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood 2005; 105: 4849\u20134852.", "journal-title": "Blood"}, {"key": "BFleu2008278_CR12", "doi-asserted-by": "publisher", "first-page": "2202", "DOI": "10.1038/sj.leu.2404425", "volume": "20", "author": "K De Keersmaecker", "year": "2006", "unstructured": "De Keersmaecker K, Lahortiga I, Graux C, Marynen P, Maertens J, Cools J et al. Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia. Leukemia 2006; 20: 2202\u20132204.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR13", "doi-asserted-by": "publisher", "first-page": "1496", "DOI": "10.1038/sj.leu.2404302", "volume": "20", "author": "C Graux", "year": "2006", "unstructured": "Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A . Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006; 20: 1496\u20131510.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR14", "doi-asserted-by": "publisher", "first-page": "1117", "DOI": "10.1038/leu.2008.80", "volume": "22", "author": "A Quint\u00e1s-Cardama", "year": "2008", "unstructured": "Quint\u00e1s-Cardama A, Tong W, Manshouri T, Vega F, Lennon PA, Cools J et al. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Leukemia 2008; 22: 1117\u20131124.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR15", "author": "E Jaffe", "first-page": "84", "year": "2001", "unstructured": "Jaffe E, Harris N, Stein H, Vardiman J . World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001, pp 84\u201386.", "volume-title": "World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "BFleu2008278_CR16", "first-page": "1783", "volume": "9", "author": "MC Bene", "year": "1995", "unstructured": "Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783\u20131786.", "journal-title": "Leukemia"}, {"key": "BFleu2008278_CR17", "author": "H Drexler", "first-page": "360", "year": "2000", "unstructured": "Drexler H (ed) The Leukemia-Lymphoma Cell Line FactsBook. Academic Press: London, 2000, pp 360\u2013361.", "volume-title": "The Leukemia-Lymphoma Cell Line FactsBook"}, {"key": "BFleu2008278_CR18", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.1002/ijc.2910250604", "volume": "25", "author": "Z Ravid", "year": "1980", "unstructured": "Ravid Z, Golblum N, Zaizov R, Schlesinger M, Kertes T, Minowada J et al. Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer 1980; 25: 705\u2013710.", "journal-title": "Int J Cancer"}, {"key": "BFleu2008278_CR19", "author": "LG Shaffer", "year": "2005", "unstructured": "Shaffer LG, Tommerup N (eds) ISCN (2005). An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 2005.", "volume-title": "ISCN (2005). An International System for Human Cytogenetic Nomenclature"}, {"key": "BFleu2008278_CR20", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1016/j.molcel.2008.05.005", "volume": "31", "author": "K De Keersmaecker", "year": "2008", "unstructured": "De Keersmaecker K, Rocnik JL, Bernad R, Lee BH, Leeman D, Folens C et al. Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. Mol Cell 2008; 31: 134\u2013142.", "journal-title": "Mol Cell"}, {"key": "BFleu2008278_CR21", "first-page": "1245", "volume": "65", "author": "EA Hurley", "year": "1991", "unstructured": "Hurley EA, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G et al. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 1991; 65: 1245\u20131254.", "journal-title": "J Virol"}, {"key": "BFleu2008278_CR22", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1016/j.yexcr.2004.09.001", "volume": "302", "author": "N Shimizu", "year": "2005", "unstructured": "Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T . When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Experimental Cell Research 2005; 302: 233\u2013243.", "journal-title": "Experimental Cell Research"}, {"key": "BFleu2008278_CR23", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1002/1098-2264(2000)9999:9999<::AID-GCC1046>3.0.CO;2-H", "volume": "29", "author": "I Solovei", "year": "2000", "unstructured": "Solovei I, Kienle D, Little G, Eils R, Savelyeva L, Schwab M et al. Topology of double minutes (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines. Genes Chromosomes Cancer 2000; 29: 297\u2013308.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BFleu2008278_CR24", "first-page": "1333", "volume": "49", "author": "GM Wahl", "year": "1989", "unstructured": "Wahl GM . The importance of circular DNA in mammalian gene amplification. Cancer Res 1989; 49: 1333\u20131340.", "journal-title": "Cancer Res"}, {"key": "BFleu2008278_CR25", "doi-asserted-by": "publisher", "first-page": "1145", "DOI": "10.1182/blood-2004-01-0388", "volume": "104", "author": "M Levis", "year": "2004", "unstructured": "Levis M, Pham R, Smith BD, Small D . In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects. Blood 2004; 104: 1145\u20131150.", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/leu2008278.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2008278", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2008278.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T09:03:00Z", "timestamp": 1555750980000}, "score": 30.073708, "issued": {"date-parts": [[2008, 10, 16]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2009, 1]]}, "issue": "1"}, "alternative-id": ["BFleu2008278"], "URL": "http://dx.doi.org/10.1038/leu.2008.278", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:13:31Z", "timestamp": 1575530011973}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "22", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 12, 2]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Background: Infections pose a considerable threat for children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) and although severe neutropenia is the most important predisposing factor, neutrophil dysfunction may contribute to this process. Neutrophil extracellular traps (NETs) bind and kill bacteria and fungi by providing a high local concentration of antimicrobial molecules. A crucial step in NET formation is the hydrogen peroxide-dependent translocation of neutrophil elastase (NE) from azurophilic granules to the nucleus. Myeloperoxidase (MPO) follows NE to the nucleus where both promote chromatin decondensation. Data on the production of NETs in leukemia patients are scant.</jats:p>\n               <jats:p>Patients and Methods: All consecutive male and female pediatric leukemia patients treated in our Pediatric Hemato-Oncology Department between 01/03/14-31/09/15 were initially recruited to this prospective study. Phagocytosis, hydrogen peroxide production, NE and MPO enzymatic activity and NETs production were studied at the end of induction and the occurrence of neutropenia, fever and infections during the first 2 months of intensive chemotherapy recorded. The study was approved by the local IRB. All parents signed an informed consent form.</jats:p>\n               <jats:p>Results: Of 22 consecutive male and female pediatric leukemia patients initially recruited, excluded were 1 AML patient with a subsequent diagnosis of shortened telomeres that could affect neutrophil function, 1 Philadelphia chromosome-positive ALL patient that received imatinib in combination with intensive chemotherapy and 3 AML patients that had partial results that did not include NETs. Therefore, the final study group (n=17) comprised 10 ALL patients (7 primary, 2 secondary and 1 relapsed) and 7 AML patients (5 primary and 2 relapsed). There were 10 males and 7 females with a median age [Q1, Q3] of 7.6 years [1.9 years and 11.2 years]. All patients entered complete remission after induction. On the day of examination, patients with AML had a higher median absolute neutrophil count than those with ALL (2800 vs 750 cells/\u03bcL) that approached statistical significance (P = .06). Nevertheless, NE activity and NETs were significantly lower among patients with AML than those with ALL (median [Q1, Q3] of 40.5% [36%, 43%] vs 90% [57%, 115%], P = .005 and 51% [9%, 56%] vs 93.5% [74%, 100%], P = .008, respectively), while there were no differences in the other neutrophil functions studied. Patients with AML had more episodes of febrile neutropenia (100% vs 40%, AML vs ALL, respectively, P = .011) and a trend for more invasive bacterial and fungal infection. Interestingly, there was no difference in the number of days with neutropenia (absolute neutrophil count \u2264500) during the first 2 months of chemotherapy between the 2 groups [median [Q1, Q3] of 32 days [30.5, 36.5] in AML vs 30 days [25, 43] in ALL, P = 0.87) (Tables 1 and 2, Figure 1).</jats:p>\n               <jats:p>Discussion: We have shown for the first time that NE activity and NETs formation are significantly decreased after induction chemotherapy in pediatric AML but not in pediatric ALL. This phenomenon in AML might be related to immaturity of the NE in neutrophils released from a recovering bone marrow after induction or to down-regulation of NE activity by a yet unknown cellular factor and might contribute to an increased rate of infections among this vulnerable population. Further studies are needed to elucidate on this topic.</jats:p>\n               <jats:p />\n               <jats:sec>\n                  <jats:title>Disclosures</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v128.22.4001.4001", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T18:52:13Z", "timestamp": 1570906333000}, "page": "4001-4001", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reduced Neutrophil Elastase Activity and Neutrophil Extracellular Traps Formation in Pediatric Acute Myeloid Leukemia but Not in Pediatric Acute Lymphoblastic Leukemia"], "prefix": "10.1182", "volume": "128", "author": [{"given": "Sivan", "family": "Berger-Achituv", "sequence": "first", "affiliation": [{"name": "Pediatric Hemato-oncology Department, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}, {"name": "Research Laboratory for Pediatric Hemato-Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}]}, {"given": "Ronit", "family": "Elhasid", "sequence": "additional", "affiliation": [{"name": "Pediatric Hemato-oncology Department, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}, {"name": "Research Laboratory for Pediatric Hemato-Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}, {"name": "Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}]}, {"given": "Yehonatan", "family": "Gottlieb", "sequence": "additional", "affiliation": [{"name": "Research Laboratory for Pediatric Hemato-Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/128/22/4001/114228/Reduced-Neutrophil-Elastase-Activity-and", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/128/22/4001/114228/Reduced-Neutrophil-Elastase-Activity-and", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T20:25:40Z", "timestamp": 1574195140000}, "score": 30.067518, "issued": {"date-parts": [[2016, 12, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 12, 2]]}, "issue": "22"}, "URL": "http://dx.doi.org/10.1182/blood.v128.22.4001.4001", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:44:13Z", "timestamp": 1574135053205}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2001, 10, 1]], "date-time": "2001-10-01T00:00:00Z", "timestamp": 1001894400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2001, 10]]}, "DOI": "10.1038/sj.leu.2402249", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T21:04:31Z", "timestamp": 1032469471000}, "page": "1495-1504", "source": "Crossref", "is-referenced-by-count": 151, "title": ["A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia"], "prefix": "10.1038", "volume": "15", "author": [{"given": "OA", "family": "Bernard", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Busson-LeConiat", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Ballerini", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Mauchauff\u00e9", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Della Valle", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Monni", "sequence": "additional", "affiliation": []}, {"given": "F Nguyen", "family": "Khac", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Mercher", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Penard-Lacronique", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Pasturaud", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Gressin", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Heilig", "sequence": "additional", "affiliation": []}, {"given": "M-T", "family": "Daniel", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Lessard", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Berger", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 10, 4]]}, "reference": [{"key": "BF2402249_CR1", "first-page": "1560", "volume": "72", "author": "SC Raimondi", "year": "1988", "unstructured": "Raimondi SC, Behm FG, Roberson PK, Pui CH, Rivera GK, Murphy SB, Williams DL . Cytogenetics of childhood T-cell leukemia Blood 1988 72: 1560\u20131566", "journal-title": "Blood"}, {"key": "BF2402249_CR2", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/0165-4608(90)90199-K", "volume": "44", "author": "R Berger", "year": "1990", "unstructured": "Berger R, Le Coniat M, Vecchione D, Derre J, Chen SJ . Cytogenetic studies of 44 T-cell acute lymphoblastic leukemias Cancer Genet Cytogenet 1990 44: 69\u201375", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2402249_CR3", "first-page": "68", "volume": "5", "author": "R Berger", "year": "1998", "unstructured": "Berger R . Cytogenetics in adult acute lymphoblastic leukemia Rev Clin Exp Hematol 1998 5: 68\u201384", "journal-title": "Rev Clin Exp Hematol"}, {"key": "BF2402249_CR4", "doi-asserted-by": "publisher", "first-page": "1270", "DOI": "10.1200/JCO.1998.16.4.1270", "volume": "16", "author": "NA Heerema", "year": "1998", "unstructured": "Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG, Lange BJ, Hutchinson RS, Reaman GH, Trigg ME, Arthur DC, Gaynon PS, Uckun FM . Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group J Clin Oncol 1998 16: 1270\u20131278", "journal-title": "J Clin Oncol"}, {"key": "BF2402249_CR5", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1002/gcc.2870090307", "volume": "9", "author": "SP Romana", "year": "1994", "unstructured": "Romana SP, Le Coniat M, Berger R . t(12;21): a new recurrent translocation in acute lymphoblastic leukemia Genes Chromosomes Cancer 1994 9: 186\u2013191", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2402249_CR6", "first-page": "2038", "volume": "93", "author": "JD Rowley", "year": "1999", "unstructured": "Rowley JD, Reshmi S, Carlson K, Roulston D . Spectral karyotype analysis of T-cell acute leukemia Blood 1999 93: 2038\u20132042", "journal-title": "Blood"}, {"key": "BF2402249_CR7", "doi-asserted-by": "publisher", "first-page": "10315", "DOI": "10.1074/jbc.275.14.10315", "volume": "275", "author": "D Avram", "year": "2000", "unstructured": "Avram D, Fields A, Pretty On Top K, Nevrivy DJ, Ishmael JE, Leid M . Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors J Biol Chem 2000 275: 10315\u201310322", "journal-title": "J Biol Chem"}, {"key": "BF2402249_CR8", "doi-asserted-by": "publisher", "first-page": "3178", "DOI": "10.1128/MCB.20.9.3178-3186.2000", "volume": "20", "author": "T Nakamura", "year": "2000", "unstructured": "Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG . Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product Mol Cell Biol 2000 20: 3178\u20133186", "journal-title": "Mol Cell Biol"}, {"key": "BF2402249_CR9", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1006/geno.2000.6385", "volume": "70", "author": "Y Saiki", "year": "2000", "unstructured": "Saiki Y, Yamazaki Y, Yoshida M, Katoh O, Nakamura T . Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells Genomics 2000 70: 387\u2013391", "journal-title": "Genomics"}, {"key": "BF2402249_CR10", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1006/bbrc.2000.3788", "volume": "278", "author": "P Koch", "year": "2000", "unstructured": "Koch P, Bohlmann I, Schafer M, Hansen-Hagge TE, Kiyoi H, Wilda M, Hameister H, Bartram CR, Janssen JW . Identification of a novel putative Ran-binding protein and its close homologue Biochem Biophys Res Commun 2000 278: 241\u2013249", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BF2402249_CR11", "doi-asserted-by": "publisher", "first-page": "40163", "DOI": "10.1074/jbc.M006242200", "volume": "275", "author": "U Kutay", "year": "2000", "unstructured": "Kutay U, Hartmann E, Treichel N, Calado A, Carmo-Fonseca M, Prehn S, Kraft R, Gorlich D, Bischoff FR . Identification of two novel RanGTP-binding proteins belonging to the importin beta superfamily J Biol Chem 2000 275: 40163\u201340168", "journal-title": "J Biol Chem"}, {"key": "BF2402249_CR12", "first-page": "2996", "volume": "78", "author": "ID Dube", "year": "1991", "unstructured": "Dube ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi SC, Crist WM, Carroll AJ, Minowada J et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) Blood 1991 78: 2996\u20133003", "journal-title": "Blood"}, {"key": "BF2402249_CR13", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1126/science.1676542", "volume": "253", "author": "M Hatano", "year": "1991", "unstructured": "Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ . Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia Science 1991 253: 79\u201382", "journal-title": "Science"}, {"key": "BF2402249_CR14", "doi-asserted-by": "publisher", "first-page": "8900", "DOI": "10.1073/pnas.88.20.8900", "volume": "88", "author": "MA Kennedy", "year": "1991", "unstructured": "Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH . HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24 Proc Natl Acad Sci USA 1991 88: 8900\u20138904", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402249_CR15", "doi-asserted-by": "publisher", "first-page": "2905", "DOI": "10.1002/j.1460-2075.1991.tb07840.x", "volume": "10", "author": "M Lu", "year": "1991", "unstructured": "Lu M, Gong ZY, Shen WF, Ho AD . The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein Embo J 1991 10: 2905\u20132910", "journal-title": "Embo J"}, {"key": "BF2402249_CR16", "doi-asserted-by": "publisher", "first-page": "4431", "DOI": "10.1073/pnas.90.10.4431", "volume": "90", "author": "TN Dear", "year": "1993", "unstructured": "Dear TN, Sanchez-Garcia I, Rabbitts TH . The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes Proc Natl Acad Sci USA 1993 90: 4431\u20134435", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402249_CR17", "author": "F Mitelman", "year": "1998", "unstructured": "Mitelman F, Johansson B, Mertens F . Catalog of Chromosome Aberrations in Cancers Wiley-Liss, New York 1998", "volume-title": "Catalog of Chromosome Aberrations in Cancers"}, {"key": "BF2402249_CR18", "first-page": "285", "volume": "76", "author": "TC Meeker", "year": "1990", "unstructured": "Meeker TC, Hardy D, Willman C, Hogan T, Abrams J . Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia Blood 1990 76: 285\u2013289", "journal-title": "Blood"}, {"key": "BF2402249_CR19", "first-page": "773", "volume": "94", "author": "RJ Jaju", "year": "1999", "unstructured": "Jaju RJ, Haas OA, Neat M, Harbott J, Saha V, Boultwood J, Brown JM, Pirc-Danoewinata H, Krings BW, Muller U, Morris SW, Wainscoat JS, Kearney L . A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG) Blood 1999 94: 773\u2013780", "journal-title": "Blood"}, {"key": "BF2402249_CR20", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1146/annurev.cellbio.15.1.607", "volume": "15", "author": "D Gorlich", "year": "1999", "unstructured": "Gorlich D, Kutay U . Transport between the cell nucleus and the cytoplasm Annu Rev Cell Dev Biol 1999 15: 607\u2013660", "journal-title": "Annu Rev Cell Dev Biol"}, {"key": "BF2402249_CR21", "first-page": "1539", "volume": "8", "author": "JA Whitlock", "year": "1994", "unstructured": "Whitlock JA, Raimondi SC, Harbott J, Morris SW, McCurley TL, Hansen-Hagge TE, Ludwig WD, Weimann G, Bartram CR . t(5;14)(q33\u201334;q11), a new recurring cytogenetic abnormality in childhood acute leukemia Leukemia 1994 8: 1539\u20131543", "journal-title": "Leukemia"}, {"key": "BF2402249_CR22", "first-page": "1781", "volume": "13", "author": "N Zhang", "year": "1996", "unstructured": "Zhang N, Shen W, Ho AD, Lu M . Three distinct domains in the HOX-11 homeobox oncoprotein are required for optimal transactivation Oncogene 1996 13: 1781\u20131787", "journal-title": "Oncogene"}, {"key": "BF2402249_CR23", "first-page": "337", "volume": "57", "author": "RG Hawley", "year": "1997", "unstructured": "Hawley RG, Fong AZ, Reis MD, Zhang N, Lu M, Hawley TS . Transforming function of the HOX11/TCL3 homeobox gene Cancer Res 1997 57: 337\u2013345", "journal-title": "Cancer Res"}, {"key": "BF2402249_CR24", "doi-asserted-by": "publisher", "first-page": "13853", "DOI": "10.1073/pnas.95.23.13853", "volume": "95", "author": "MR Hough", "year": "1998", "unstructured": "Hough MR, Reis MD, Singaraja R, Bryce DM, Kamel-Reid S, Dardick I, Breitman ML, Dube ID . A model for spontaneous B-lineage lymphomas in IgHmu-HOX11 transgenic mice Proc Natl Acad Sci USA 1998 95: 13853\u201313858", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402249_CR25", "first-page": "877", "volume": "92", "author": "G Keller", "year": "1998", "unstructured": "Keller G, Wall C, Fong AZ, Hawley TS, Hawley RG . Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential Blood 1998 92: 877\u2013887", "journal-title": "Blood"}, {"key": "BF2402249_CR26", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/0925-4773(93)90016-Q", "volume": "44", "author": "K Raju", "year": "1993", "unstructured": "Raju K, Tang S, Dube ID, Kamel-Reid S, Bryce DM, Breitman ML . Characterization and developmental expression of Tlx-1, the murine homolog of HOX11 Mech Dev 1993 44: 51\u201364", "journal-title": "Mech Dev"}, {"key": "BF2402249_CR27", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1007/s004290050061", "volume": "195", "author": "M Hatano", "year": "1997", "unstructured": "Hatano M, Iitsuka Y, Yamamoto H, Dezawa M, Yusa S, Kohno Y, Tokuhisa T . Ncx, a Hox11 related gene, is expressed in a variety of tissues derived from neural crest cells Anat Embryol (Berl) 1997 195: 419\u2013425", "journal-title": "Anat Embryol (Berl)"}, {"key": "BF2402249_CR28", "doi-asserted-by": "publisher", "first-page": "5389", "DOI": "10.1523/JNEUROSCI.18-14-05389.1998", "volume": "18", "author": "C Logan", "year": "1998", "unstructured": "Logan C, Wingate RJ, McKay IJ, Lumsden A . Tlx-1 and Tlx-3 homeobox gene expression in cranial sensory ganglia and hindbrain of the chick embryo: markers of patterned connectivity J Neurosci 1998 18: 5389\u20135402", "journal-title": "J Neurosci"}, {"key": "BF2402249_CR29", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1002/(SICI)1097-0177(199901)214:1<34::AID-DVDY4>3.0.CO;2-R", "volume": "214", "author": "KD Patterson", "year": "1999", "unstructured": "Patterson KD, Krieg PA . Hox11-family genes XHox11 and XHox11L2 in xenopus: XHox11L2 expression is restricted to a subset of the primary sensory neurons Dev Dyn 1999 214: 34\u201343", "journal-title": "Dev Dyn"}, {"key": "BF2402249_CR30", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/S0304-3940(99)00637-0", "volume": "273", "author": "K Uchiyama", "year": "1999", "unstructured": "Uchiyama K, Otsuka R, Hanaoka K . CHox11L2, a Hox11 related gene, is expressed in the peripheral nervous system and subpopulation of the spinal cord during chick development Neurosci Lett 1999 273: 97\u2013100", "journal-title": "Neurosci Lett"}, {"key": "BF2402249_CR31", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1038/368747a0", "volume": "368", "author": "CW Roberts", "year": "1994", "unstructured": "Roberts CW, Shutter JR, Korsmeyer SJ . Hox11 controls the genesis of the spleen Nature 1994 368: 747\u2013749", "journal-title": "Nature"}, {"key": "BF2402249_CR32", "first-page": "2909", "volume": "121", "author": "TN Dear", "year": "1995", "unstructured": "Dear TN, Colledge WH, Carlton MB, Lavenir I, Larson T, Smith AJ, Warren AJ, Evans MJ, Sofroniew MV, Rabbitts TH . The Hox11 gene is essential for cell survival during spleen development Development 1995 121: 2909\u20132915", "journal-title": "Development"}, {"key": "BF2402249_CR33", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1172/JCI119593", "volume": "100", "author": "M Hatano", "year": "1997", "unstructured": "Hatano M, Aoki T, Dezawa M, Yusa S, Iitsuka Y, Koseki H, Taniguchi M, Tokuhisa T . A novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient mice J Clin Invest 1997 100: 795\u2013801", "journal-title": "J Clin Invest"}, {"key": "BF2402249_CR34", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1038/73516", "volume": "24", "author": "S Shirasawa", "year": "2000", "unstructured": "Shirasawa S, Arata A, Onimaru H, Roth KA, Brown GA, Horning S, Arata S, Okumura K, Sasazuki T, Korsmeyer SJ . Rnx deficiency results in congenital central hypoventilation Nat Genet 2000 24: 287\u2013290", "journal-title": "Nat Genet"}, {"key": "BF2402249_CR35", "first-page": "542a", "volume": "96", "author": "T Sonoki", "year": "2000", "unstructured": "Sonoki T, Satterwhite E, Willis TG, Siebert R, Nowak R, Arriola EL, Liu H, Harder L, Gesk S, Steinemann D, Oscier DG, Schelgelberger B, Tucker PW, Dyers MJS . The BCL11 gene family: deregulated expression of BCL11A in lymphoma Blood 2000 96: (Suppl. 1) 542a", "journal-title": "Blood"}, {"key": "BF2402249_CR36", "first-page": "2760", "volume": "93", "author": "CG Begley", "year": "1999", "unstructured": "Begley CG, Green AR . The SCL gene: from case report to critical hematopoietic regulator Blood 1999 93: 2760\u20132770", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2402249.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402249", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402249.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T20:41:23Z", "timestamp": 1552682483000}, "score": 30.015078, "issued": {"date-parts": [[2001, 10]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2001, 10]]}, "issue": "10"}, "alternative-id": ["BF2402249"], "URL": "http://dx.doi.org/10.1038/sj.leu.2402249", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:40:57Z", "timestamp": 1574113257207}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1997, 8, 1]], "date-time": "1997-08-01T00:00:00Z", "timestamp": 870393600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[1997, 8]]}, "DOI": "10.1038/sj.leu.2400737", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T18:24:17Z", "timestamp": 1031163857000}, "page": "1360-1363", "source": "Crossref", "is-referenced-by-count": 8, "title": ["A new breakpoint, telomeric to TEL/ETV6, on the short arm of chromosome 12 in T cell acute lymphoblastic leukemia"], "prefix": "10.1038", "volume": "11", "author": [{"given": "M", "family": "Le Coniat", "sequence": "first", "affiliation": []}, {"given": "V", "family": "Della Valle", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Marynen", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Berger", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1997, 12, 18]]}, "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2400737.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2400737", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2400737.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T04:23:47Z", "timestamp": 1552710227000}, "score": 29.76632, "issued": {"date-parts": [[1997, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 8]]}, "issue": "8"}, "alternative-id": ["BF2400737"], "URL": "http://dx.doi.org/10.1038/sj.leu.2400737", "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T16:45:13Z", "timestamp": 1574268313851}, "reference-count": 8, "publisher": "SAGE Publications", "issue": "1", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Dev Pathol"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.2350/06-03-0057.1", "type": "journal-article", "created": {"date-parts": [[2007, 1, 23]], "date-time": "2007-01-23T01:16:48Z", "timestamp": 1169515008000}, "page": "41-45", "source": "Crossref", "is-referenced-by-count": 9, "title": ["CD5-Positive B-Cell Acute Lymphoblastic Leukemia"], "prefix": "10.1177", "volume": "10", "author": [{"given": "Michael R.", "family": "Peterson", "sequence": "first", "affiliation": [{"name": "Department of Pathology, University of California, San Diego, CA 92093, USA"}]}, {"given": "Kyle J.", "family": "Noskoviak", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, University of California, San Diego, CA 92093, USA"}]}, {"given": "Robert", "family": "Newbury", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Children's Hospital and Health Center of San Diego, San Diego, CA 92123, USA"}]}], "member": "179", "published-online": {"date-parts": [[2008, 9]]}, "reference": [{"key": "bibr1-06-03-0057.1", "author": "Kipps TJ", "volume": "47", "first-page": "117", "year": "1989", "journal-title": "Adv Immunol", "DOI": "10.1016/S0065-2776(08)60663-X", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "bibr2-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1002/(SICI)1096-911X(199812)31:6<551::AID-MPO23>3.0.CO;2-E", "volume": "31", "author": "Subira D", "year": "1998", "journal-title": "Med Pediatr Oncol"}, {"issue": "2", "key": "bibr3-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1002/ajh.20163", "volume": "77", "author": "Lau LG", "year": "2004", "journal-title": "Am J Hematol"}, {"issue": "3", "key": "bibr4-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1016/S0740-2570(03)00031-5", "volume": "20", "author": "Brunning RD", "year": "2003", "journal-title": "Semin Diagn Pathol"}, {"issue": "4", "key": "bibr5-06-03-0057.1", "first-page": "1011", "volume": "79", "author": "Behm FG", "year": "1992", "journal-title": "Blood"}, {"issue": "2", "key": "bibr6-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/S0165-4608(98)00145-9", "volume": "109", "author": "Wong KF", "year": "1999", "journal-title": "Cancer Genet Cytogenet"}, {"issue": "3", "key": "bibr7-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1532/IJH97.04169", "volume": "81", "author": "Takahashi T", "year": "2005", "journal-title": "Int J Hematol"}, {"issue": "1", "key": "bibr8-06-03-0057.1", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1002/gcc.2870080111", "volume": "8", "author": "Antonini P", "year": "1993", "journal-title": "Genes Chromosomes Cancer"}], "container-title": ["Pediatric and Developmental Pathology"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.2350/06-03-0057.1", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/full-xml/10.2350/06-03-0057.1", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.2350/06-03-0057.1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 26]], "date-time": "2017-12-26T20:22:39Z", "timestamp": 1514319759000}, "score": 29.765059, "issued": {"date-parts": [[2007, 1]]}, "references-count": 8, "journal-issue": {"published-online": {"date-parts": [[2008, 9]]}, "published-print": {"date-parts": [[2007, 1]]}, "issue": "1"}, "alternative-id": ["10.2350/06-03-0057.1"], "URL": "http://dx.doi.org/10.2350/06-03-0057.1", "relation": {"cites": []}, "ISSN": ["1093-5266", "1615-5742"], "issn-type": [{"value": "1093-5266", "type": "print"}, {"value": "1615-5742", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:34:03Z", "timestamp": 1574433243295}, "publisher-location": "Berlin, Heidelberg", "reference-count": 13, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642848971", "type": "print"}, {"value": "9783642848957", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1993]]}, "DOI": "10.1007/978-3-642-84895-7_14", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 14]], "date-time": "2011-12-14T09:17:42Z", "timestamp": 1323854262000}, "page": "149-155", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Molecular Genetic Techniques for Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia: Possibilities and Limitations"], "prefix": "10.1007", "author": [{"given": "C. R.", "family": "Bartram", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "14_CR1", "first-page": "163", "volume": "76", "author": "D Campana", "year": "1990", "unstructured": "Campana D, Coustan-Smith E, Janossy G (1990a) The immunologic detection of residual disease in acute leukemia. Blood 76: 163\u2013171", "journal-title": "Blood"}, {"key": "14_CR2", "first-page": "609", "volume": "4", "author": "D Campana", "year": "1990", "unstructured": "Campana D, Yokota S, Coustan-Smith E, Hansen-Hagge TE, Janossy G, Bartram CR (1990b) The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study. Leukemia 4: 609\u2013614", "journal-title": "Leukemia"}, {"key": "14_CR3", "first-page": "2051", "volume": "73", "author": "R Champlin", "year": "1989", "unstructured": "Champlin R, Gale RP (1989) Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 73: 2051\u20132066", "journal-title": "Blood"}, {"key": "14_CR4", "first-page": "155", "volume": "3", "author": "L D\u2019Auriol", "year": "1989", "unstructured": "D\u2019Auriol L, Maclntyre E, Galibert E, Sigaux (1989) In vitro amplification of T cell y gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. Leukemia 3: 155\u2013158", "journal-title": "Leukemia"}, {"key": "14_CR5", "first-page": "1762", "volume": "74", "author": "TE Hansen-Hagge", "year": "1989", "unstructured": "Hansen-Hagge TE, Yokota S, Bartram CR (1989) Detection of minimal residuai disease inacute lymphoblastic leukemia by in vitro amplification of rear-ranged T- cell receptor \u03b4 chain sequences. Blood 74: 1762\u20131767", "journal-title": "Blood"}, {"key": "14_CR6", "doi-asserted-by": "publisher", "first-page": "990", "DOI": "10.1056/NEJM198810133191506", "volume": "319", "author": "R Kurzrock", "year": "1988", "unstructured": "Kurzrock R, Gutterman JU, Talpaz M (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319: 990\u2013998", "journal-title": "N Engl J Med"}, {"key": "14_CR7", "doi-asserted-by": "publisher", "first-page": "2125", "DOI": "10.1172/JCI114951", "volume": "86", "author": "EA Maclntyre", "year": "1990", "unstructured": "Maclntyre EA, d\u2019Auriol L, Duparc C, Leverger G, Galibert F, Sigaux F (1990) Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining juncitonal sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J Clin Invest 86: 2125\u20132135", "journal-title": "J Clin Invest"}, {"key": "14_CR8", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1016/0140-6736(91)91706-Z", "volume": "337", "author": "J Maurer", "year": "1991", "unstructured": "Maurer J, Janssen J WG, Thiel E, van Denderen J, Ludwig WD, Aydemir \u00dc, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR (1991) Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction. Lancet 337: 1055\u20131058", "journal-title": "Lancet"}, {"key": "14_CR9", "first-page": "1079", "volume": "70", "author": "A Raghavachar", "year": "1987", "unstructured": "Raghavachar A, Thiel E, Bartram CR (1987) Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse. Blood 70: 1079\u20131083", "journal-title": "Blood"}, {"key": "14_CR10", "doi-asserted-by": "publisher", "first-page": "487", "DOI": "10.1126/science.2448875", "volume": "239", "author": "RK Saiki", "year": "1988", "unstructured": "Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487\u2013491", "journal-title": "Science"}, {"key": "14_CR11", "doi-asserted-by": "publisher", "first-page": "5123", "DOI": "10.1073/pnas.86.13.5123", "volume": "86", "author": "M Yamada", "year": "1989", "unstructured": "Yamada M, Hudson S, Tournay O, Bittenbender S, Shane SS, Lange B, Tsujimoto Y, Caton AJ, Rovera G (1989) Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region ( CDR-III) specific probes. Proc Natl Acad Sci USA 86: 5123\u20135127", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "14_CR12", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1056/NEJM199008163230705", "volume": "323", "author": "M Yamada", "year": "1990", "unstructured": "Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G (1990) Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemia cells during the first 18 months of treatment. N Engl J med 323: 488\u2013495", "journal-title": "N Engl J med"}, {"key": "14_CR13", "first-page": "331", "volume": "77", "author": "S Yokota", "year": "1991", "unstructured": "Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR (1991) The use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 77: 331\u2013339", "journal-title": "Blood"}], "container-title": ["Recent Advances in Cell Biology of Acute Leukemia", "Recent Results in Cancer Research"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-84895-7_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T17:30:27Z", "timestamp": 1572888627000}, "score": 29.565105, "issued": {"date-parts": [[1993]]}, "ISBN": ["9783642848971", "9783642848957"], "references-count": 13, "URL": "http://dx.doi.org/10.1007/978-3-642-84895-7_14", "relation": {"cites": []}, "ISSN": ["0080-0015"], "issn-type": [{"value": "0080-0015", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:27:16Z", "timestamp": 1575178036953}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 4, 1]], "date-time": "2006-04-01T00:00:00Z", "timestamp": 1143849600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2006, 4]]}, "DOI": "10.1016/j.leukres.2005.08.013", "type": "journal-article", "created": {"date-parts": [[2005, 9, 27]], "date-time": "2005-09-27T14:19:16Z", "timestamp": 1127830756000}, "page": "487-489", "source": "Crossref", "is-referenced-by-count": 5, "title": ["HLA-DM expression is elevated in ETV6\u2013AML1 translocation-positive pediatric acute lymphoblastic leukemia"], "prefix": "10.1016", "volume": "30", "author": [{"given": "Wasil A.", "family": "Jastaniah", "sequence": "first", "affiliation": []}, {"given": "Angela J.", "family": "Alessandri", "sequence": "additional", "affiliation": []}, {"given": "Gregor S.D.", "family": "Reid", "sequence": "additional", "affiliation": []}, {"given": "Kirk R.", "family": "Schultz", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212605003255?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212605003255?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T02:58:40Z", "timestamp": 1548125920000}, "score": 29.430855, "issued": {"date-parts": [[2006, 4]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2006, 4]]}, "issue": "4"}, "alternative-id": ["S0145212605003255"], "URL": "http://dx.doi.org/10.1016/j.leukres.2005.08.013", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}], "subject": ["Cancer Research", "Oncology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:43:14Z", "timestamp": 1574098994834}, "reference-count": 12, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 10, 1]], "date-time": "2001-10-01T00:00:00Z", "timestamp": 1001894400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[2001, 10]]}, "DOI": "10.1016/s0165-4608(01)00459-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T16:25:09Z", "timestamp": 1027614309000}, "page": "84-86", "source": "Crossref", "is-referenced-by-count": 2, "title": ["B-cell acute lymphoblastic leukemia with tandem t(14;14)(q11;q32)"], "prefix": "10.1016", "volume": "130", "author": [{"given": "Roland", "family": "Berger", "sequence": "first", "affiliation": []}, {"given": "Maryvonne", "family": "Busson", "sequence": "additional", "affiliation": []}, {"given": "Marie-Th\u00e9r\u00e8se", "family": "Daniel", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165460801004599?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165460801004599?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 26]], "date-time": "2019-04-26T02:55:09Z", "timestamp": 1556247309000}, "score": 29.269732, "issued": {"date-parts": [[2001, 10]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2001, 10]]}, "issue": "1"}, "alternative-id": ["S0165460801004599"], "URL": "http://dx.doi.org/10.1016/s0165-4608(01)00459-9", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:59:37Z", "timestamp": 1574405977744}, "publisher-location": "Dordrecht", "reference-count": 22, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789400991521", "type": "print"}, {"value": "9789400991507", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1980]]}, "DOI": "10.1007/978-94-009-9150-7_37", "type": "book-chapter", "created": {"date-parts": [[2011, 10, 5]], "date-time": "2011-10-05T13:51:02Z", "timestamp": 1317822662000}, "page": "481-487", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Prognostic Relevance of Leukemic Cell Typing in Acute Lymphoblastic Leukemia"], "prefix": "10.1007", "author": [{"given": "R.", "family": "Willemze", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "37_CR1", "author": "Van der Does-van den Berg, A. (Stichting Nederlandse Werkgroep Leukemie bij kinderen (SNWLK))", "first-page": "181", "year": "1978", "unstructured": "Van der Does-van den Berg, A. (Stichting Nederlandse Werkgroep Leukemie bij kinderen (SNWLK)): Resultaten van behandeling van acute lymfatische leukemie bij kinderen in Nederland (1965\u20131976). In: Het medisch jaar 1978, p. 181\u2013194, Scheltema en Holkema, Utrecht, Bohn, 1978.", "volume-title": "Het medisch jaar 1978"}, {"key": "37_CR2", "first-page": "823", "volume": "46", "author": "R Willemze", "year": "1975", "unstructured": "Willemze, R., Hillen, H., Hartgrink-Groeneveld, C.A. et al.: Treatment of acute lymphoblastic leukemia in adolescents and adults. Blood, 46: 823\u2013834, 1975.", "journal-title": "Blood"}, {"key": "37_CR3", "unstructured": "Willemze, R., Hillen, H., and den Ottolander, G.J. et al.: Acute lymphatische leukaemie bij adolescenten en volwassenen. Ned. Tijdschr. Geneesk., in press."}, {"key": "37_CR4", "doi-asserted-by": "publisher", "first-page": "828", "DOI": "10.1002/1097-0142(197808)42:2+<828::AID-CNCR2820420704>3.0.CO;2-W", "volume": "42", "author": "E Frei", "year": "1978", "unstructured": "Frei, E., and Sallan, S.E.: Acute lymphoblastic leukemia: treatment. Cancer, 42: 828\u2013838, 1978.", "journal-title": "Cancer"}, {"key": "37_CR5", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1111/j.1600-0609.1979.tb00416.x", "volume": "22", "author": "D Ruggero", "year": "1979", "unstructured": "Ruggero, D., Baccarani, M., and Gobbi, M. et al.: Adult acute lymphoblastic leukaemia. Study of 32 patients and analysis of prognostic factors. Scand. J. Haematol. 22: 154\u2013164, 1979.", "journal-title": "Scand. J. Haematol"}, {"key": "37_CR6", "first-page": "1307", "volume": "II", "author": "JM Chessells", "year": "1979", "unstructured": "Chessells, J.M., Hardisty, R.M., and Rapson, N.T. et al.: Acute lymphoblastic leukaemia in children: classification and prognosis. Lancet II: 1307\u20131309, 1977.", "journal-title": "Lancet"}, {"key": "37_CR7", "unstructured": "Nijmegen and Leiden series of adult A.L.L. patients."}, {"key": "37_CR8", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1002/ajh.2830020305", "volume": "2", "author": "MT Shaw", "year": "1977", "unstructured": "Shaw, M.T.: Lack of prognostic value of the periodic Acid Schiff Reaction and blast cell size in childhood acute lymphocytic leukemia. Amer. J. Hematol., 2: 237\u2013243, 1977.", "journal-title": "Amer. J. Hematol."}, {"key": "37_CR9", "first-page": "554", "volume": "16", "author": "G Math\u00e8", "year": "1971", "unstructured": "Math\u00e8, G., Pouillart, P., and Sterescu, M. et al.: Subdivision of classical varieties of acute leukemia. Correlation with prognosis and cure expentancy. Eur. J. Clin. Biol. Res., 16: 554\u2013560, 1971.", "journal-title": "Eur. J. Clin. Biol. Res."}, {"key": "37_CR10", "first-page": "23", "volume": "43", "author": "JM Bennett", "year": "1973", "unstructured": "Bennett, J.M., Klemperer, M.R., and Segel, G.B.: Survival prediction based on morphology of lymphoblasts. Rec. Res. Cancer Res., 43: 23\u201327, 1973.", "journal-title": "Rec. Res. Cancer Res."}, {"key": "37_CR11", "first-page": "7", "volume": "1", "author": "G Flandrin", "year": "1975", "unstructured": "Flandrin, G., Bernard, J.: Cytological classification of acute leukemias. A survey of 1400 cases. Blood Cells, 1: 7\u201315, 1975.", "journal-title": "Blood Cells"}, {"key": "37_CR12", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1111/j.1365-2141.1974.tb06770.x", "volume": "27", "author": "N Pantazopoulos", "year": "1974", "unstructured": "Pantazopoulos, N., and Sinks, L.F.: Morphological criteria for prognostication of acute lymphoblastic leukemia. Brit. J. Haematol., 27: 25\u201330, 1974.", "journal-title": "Brit. J. Haematol."}, {"key": "37_CR13", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1111/j.1365-2141.1975.tb00836.x", "volume": "31", "author": "SB Murphy", "year": "1975", "unstructured": "Murphy, S.B., Borella, L., and Sen. L. et al.: Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome of chilhood acute lymphoblastic leukaemia. Brit. J. Haematol., 31: 95\u2013101, 1975.", "journal-title": "Brit. J. Haematol."}, {"key": "37_CR14", "first-page": "241", "volume": "25", "author": "TF Necheles", "year": "1976", "unstructured": "Necheles, T.F., Brenner, J.F., and Fristensky, R. et al.: The computer-assisted morphological classification of acute leukemia. I. Preliminary results. Biomedicine (Exp.), 25: 241\u2013244, 1976.", "journal-title": "Biomedicine (Exp.)"}, {"key": "37_CR15", "first-page": "209", "volume": "3", "author": "SL Lee", "year": "1976", "unstructured": "Lee, S.L., Kopel, S., and Glidewell, O.: Cytomorphological determinants of prognosis in acute lymphoblastic leukemia in children. Sem. Oncol., 3: 209\u2013217, 1976.", "journal-title": "Sem. Oncol."}, {"key": "37_CR16", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1002/1097-0142(197902)43:2<551::AID-CNCR2820430222>3.0.CO;2-U", "volume": "43", "author": "GA Pangalis", "year": "1979", "unstructured": "Pangalis, G.A., Nathwani, B.N., and Rappaport, H. et al.: Acute lymphoblastic leukemia: the significance of nuclear convolutions. Cancer, 43: 551\u2013557, 1979.", "journal-title": "Cancer"}, {"key": "37_CR17", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1111/j.1365-2141.1976.tb03563.x", "volume": "33", "author": "JM Bennett", "year": "1976", "unstructured": "Bennett, J.M., Catovsky, D., and Daniel, M.T. et al.: Proposals of the classification of the acute leukaemias. Brit. J. Haematol., 33: 451\u2013458, 1976.", "journal-title": "Brit. J. Haematol."}, {"key": "37_CR18", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1002/1097-0142(197808)42:2+<817::AID-CNCR2820420703>3.0.CO;2-2", "volume": "42", "author": "JC Brouet", "year": "1978", "unstructured": "Brouet, J.C., and Seligmann, M.: The immunological classification of acute lymphoblastic leukemias. Cancer, 42: 817\u2013827, 1978.", "journal-title": "Cancer"}, {"key": "37_CR19", "first-page": "1317", "volume": "299", "author": "JD Bitran", "year": "1978", "unstructured": "Bitran, J.D.: Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia. New Engl. J. Med., 299: 1317, 1978.", "journal-title": "New Engl. J. Med"}, {"key": "37_CR20", "first-page": "557", "volume": "I", "author": "D Belpomme", "year": "1977", "unstructured": "Belpomme, D., Math\u00e9 G., Davies, A.J.S.: Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukemias. Lancet, I: 557\u2013558, 1977.", "journal-title": "Lancet"}, {"key": "37_CR21", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1016/S0140-6736(78)90861-9", "volume": "I", "author": "D Catovsky", "year": "1978", "unstructured": "Catovsky, D., Cherchi, M., and Greaves, M.F. et al.: Acid-phosphatase reaction in acute lymphoblastic leukaemia. Lancet, I: 749\u2013751, 1978.", "journal-title": "Lancet"}, {"issue": "1", "key": "37_CR22", "first-page": "238", "volume": "52", "author": "R Aur", "year": "1978", "unstructured": "Aur, R., Simone, J., and Hustu, O. et al.: Multiple combination therapy for childhood acute lymphocytic leukemia (A.L.L.). Blood, 52 (S1): 238, 1978.", "journal-title": "Blood"}], "container-title": ["Malignant Lymphoproliferative Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-94-009-9150-7_37", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 10]], "date-time": "2019-04-10T02:04:11Z", "timestamp": 1554861851000}, "score": 29.093594, "issued": {"date-parts": [[1980]]}, "ISBN": ["9789400991521", "9789400991507"], "references-count": 22, "URL": "http://dx.doi.org/10.1007/978-94-009-9150-7_37", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}